cached image

Colin L. Masters, B MED SCI (HONS), MBBS, MD, FRCPath, FRCPA, FAA - Publications

Affiliations: 
Mental Health Research Institute University of Melbourne, Parkville, Victoria, Australia 
Area:
Alzheimer's disease, amyloid
Website:
http://www.mhri.edu.au/board.htm#director

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 McDade E, Voytyuk I, Aisen P, Bateman RJ, Carrillo MC, De Strooper B, Haass C, Reiman EM, Sperling R, Tariot PN, Yan R, Masters CL, Vassar R, Lichtenthaler SF. The case for low-level BACE1 inhibition for the prevention of Alzheimer disease. Nature Reviews. Neurology. PMID 34548654 DOI: 10.1038/s41582-021-00545-1  1
2021 Mukherjee S, Perez KA, Dubois C, Nisbet RM, Li QX, Varghese S, Jin L, Birchall I, Streltsov VA, Vella LJ, McLean C, Barham KJ, Roberts BR, Masters CL. Citrullination of Amyloid-β Peptides in Alzheimer's Disease. Acs Chemical Neuroscience. PMID 34519476 DOI: 10.1021/acschemneuro.1c00474  1
2021 Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, Karikari TK, Simrén J, Vanmechelen E, Armstrong NJ, Hone E, Asih PR, Taddei K, Doré V, Villemagne VL, ... ... Masters CL, et al. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34494715 DOI: 10.1002/alz.12447  1
2021 Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A. The Amyloid-β Pathway in Alzheimer's Disease. Molecular Psychiatry. PMID 34456336 DOI: 10.1038/s41380-021-01249-0  1
2021 Huq AJ, Fulton-Howard B, Riaz M, Laws S, Sebra R, Ryan J, Renton AE, Goate AM, Masters CL, Storey E, Shah RC, Murray A, McNeil J, Winship I, et al. Polygenic score modifies risk for Alzheimer's disease in ε4 homozygotes at phenotypic extremes. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12226. PMID 34386572 DOI: 10.1002/dad2.12226  1
2021 Stehmann C, Senesi M, Sarros S, McGlade A, Lewis V, Simpson M, Klug G, McLean C, Masters CL, Collins SJ. Erratum to: Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2020. Communicable Diseases Intelligence (2018). 45. PMID 34376130 DOI: 10.33321/cdi.2021.45.40  1
2021 Fowler C, Rainey-Smith SR, Bird S, Bomke J, Bourgeat P, Brown BM, Burnham SC, Bush AI, Chadunow C, Collins S, Doecke J, Doré V, Ellis KA, Evered L, Fazlollahi A, ... ... Masters CL, et al. Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease. Journal of Alzheimer's Disease Reports. 5: 443-468. PMID 34368630 DOI: 10.3233/ADR-210005  1
2021 Chen CD, Joseph-Mathurin N, Sinha N, Zhou A, Li Y, Friedrichsen K, McCullough A, Franklin EE, Hornbeck R, Gordon B, Sharma V, Cruchaga C, Goate A, Karch C, McDade E, ... ... Masters CL, et al. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. Acta Neuropathologica. PMID 34319442 DOI: 10.1007/s00401-021-02342-y  1
2021 Stehmann C, Senesi M, Sarros S, McGlade A, Lewis V, Simpson M, Klug G, McLean CA, Masters CL, Collins SJ. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2020. Communicable Diseases Intelligence (2018). 45. PMID 34315360 DOI: 10.33321/cdi.2021.45.38  1
2021 Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, Goate A, Ances BM, Doran E, Christian BT, Lai F, Rosas HD, Schupf N, Krinsky-McHale S, Silverman W, ... ... Masters CL, et al. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 20: 615-626. PMID 34302786 DOI: 10.1016/S1474-4422(21)00139-3  1
2021 Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, ... ... Masters CL, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197  1
2021 Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, ... ... Masters CL, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine. PMID 34155411 DOI: 10.1038/s41591-021-01369-8  1
2021 Sexton CE, Anstey KJ, Baldacci F, Barnum CJ, Barron AM, Blennow K, Brodaty H, Burnham S, Elahi FM, Götz J, Jeon YH, Koronyo-Hamaoui M, Landau SM, Lautenschlager NT, Laws SM, ... ... Masters CL, et al. Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34058063 DOI: 10.1002/alz.12380  1
2021 Harrington KD, Aschenbrenner AJ, Maruff P, Masters CL, Fagan AM, Benzinger TLS, Gordon BA, Cruchaga C, Morris JC, Hassenstab J. Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older Adults. Psychological Science. 956797620985518. PMID 34043464 DOI: 10.1177/0956797620985518  1
2021 Su H, Rustam YH, Masters CL, Makalic E, McLean CA, Hill AF, Barnham KJ, Reid GE, Vella LJ. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease. Journal of Extracellular Vesicles. 10: e12089. PMID 34012516 DOI: 10.1002/jev2.12089  1
2021 Pichet Binette A, Theaud G, Rheault F, Roy M, Collins DL, Levin J, Mori H, Lee JH, Farlow MR, Schofield P, Chhatwal JP, Masters CL, Benzinger T, Morris J, Bateman R, et al. Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease. Elife. 10. PMID 33983116 DOI: 10.7554/eLife.62929  1
2021 Waller M, Buckley RF, Masters CL, Nona FR, Eades S, Dobson AJ. Deaths with Dementia in Indigenous and Non-Indigenous Australians: A Nationwide Study. Journal of Alzheimer's Disease : Jad. PMID 33967039 DOI: 10.3233/JAD-201175  1
2021 Gardener SL, Weinborn M, Sohrabi HR, Doecke JD, Bourgeat P, Rainey-Smith SR, Shen KK, Fripp J, Taddei K, Maruff P, Salvado O, Savage G, Ames D, Masters CL, Rowe CC, et al. Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults. Journal of Alzheimer's Disease : Jad. 81: 1039-1052. PMID 33935071 DOI: 10.3233/JAD-201243  1
2021 Mukherjee S, Perez KA, Lago LC, Klatt S, McLean CA, Birchall IE, Barnham KJ, Masters CL, Roberts BR. Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease. Brain Communications. 3: fcab028. PMID 33928245 DOI: 10.1093/braincomms/fcab028  1
2021 Doecke JD, Francois C, Fowler CJ, Stoops E, Bourgeat P, Rainey-Smith SR, Li QX, Masters CL, Martins RN, Villemagne VL, Collins SJ, Vanderstichele HM. Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods. Alzheimer's Research & Therapy. 13: 79. PMID 33863377 DOI: 10.1186/s13195-021-00812-9  1
2021 Gu BJ, Huang X, Avula PK, Caruso E, Drysdale C, Vessey KA, Ou A, Fowler C, Liu TH, Lin Y, Horton A, Masters CL, Wiley JS, Guymer RH, Fletcher EL. Deficits in Monocyte Function in Age Related Macular Degeneration: A Novel Systemic Change Associated With the Disease. Frontiers in Medicine. 8: 634177. PMID 33816525 DOI: 10.3389/fmed.2021.634177  1
2021 Chatterjee P, Tegg M, Pedrini S, Fagan AM, Xiong C, Singh AK, Taddei K, Gardener S, Masters CL, Schofield PR, Multhaup G, Benzinger TLS, Morris JC, Bateman RJ, Greenberg SM, et al. Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation. International Journal of Molecular Sciences. 22. PMID 33805778 DOI: 10.3390/ijms22062931  1
2021 Fernandez S, Burnham SC, Milicic L, Savage G, Maruff P, Peretti M, Sohrabi HR, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. Is Associated with Amyloid-β and ε4-Related Cognitive Decline in Cognitively Normal Adults. Journal of Alzheimer's Disease Reports. 5: 111-120. PMID 33782664 DOI: 10.3233/ADR-200246  1
2021 Huq AJ, Sexton A, Lacaze P, Masters CL, Storey E, Velakoulis D, James PA, Winship IM. Genetic testing in dementia-A medical genetics perspective. International Journal of Geriatric Psychiatry. PMID 33779003 DOI: 10.1002/gps.5535  1
2021 Lim YY, Baker JE, Mills A, Bruns L, Fowler C, Fripp J, Rainey-Smith SR, Ames D, Masters CL, Maruff P. Learning deficit in cognitively normal APOE ε4 carriers with LOW β-amyloid. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12136. PMID 33748392 DOI: 10.1002/dad2.12136  1
2021 Moussavi Nik SH, Porter T, Newman M, Bartlett B, Khan I, Sabale M, Eccles M, Woodfield A, Groth D, Dore V, Villemagne VL, Masters CL, Martins RN, Laws SM, Lardelli M, et al. Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration. Journal of Alzheimer's Disease : Jad. PMID 33720885 DOI: 10.3233/JAD-201133  1
2021 Tan S, Porter T, Bucks RS, Weinborn M, Milicic L, Brown A, Rainey-Smith SR, Taddei K, Ames D, Masters CL, Maruff P, Savage G, Rowe CC, Villemagne VL, Brown B, et al. Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognition. Hormones and Behavior. 131: 104966. PMID 33714752 DOI: 10.1016/j.yhbeh.2021.104966  1
2021 Steward CE, Venkatraman VK, Lui E, Malpas CB, Ellis KA, Cyarto EV, Vivash L, O'Brien TJ, Velakoulis D, Ames D, Masters CL, Lautenschlager NT, Bammer R, Desmond PM. Assessment of the DTI-ALPS Parameter Along the Perivascular Space in Older Adults at Risk of Dementia. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 33556226 DOI: 10.1111/jon.12837  1
2021 Liu YH, Wang J, Li QX, Fowler CJ, Zeng F, Deng J, Xu ZQ, Zhou HD, Doecke JD, Villemagne VL, Lim YY, Masters CL, Wang YJ. Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's disease. Science Advances. 7. PMID 33523832 DOI: 10.1126/sciadv.abb0457  1
2021 Doré V, Krishnadas N, Bourgeat P, Huang K, Li S, Burnham S, Masters CL, Fripp J, Villemagne VL, Rowe CC. Relationship between amyloid and tau levels and its impact on tau spreading. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33495928 DOI: 10.1007/s00259-021-05191-9  1
2021 Joseph-Mathurin N, Wang G, Kantarci K, Jack CR, McDade E, Hassenstab J, Blazey TM, Gordon BA, Su Y, Chen G, Massoumzadeh P, Hornbeck RC, Allegri RF, Ances BM, Berman SB, ... ... Masters CL, et al. Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease. Neurology. PMID 33495373 DOI: 10.1212/WNL.0000000000011542  1
2021 Lim YY, Pase MP, Buckley RF, Yassi N, Bransby L, Fowler C, Laws SM, Masters CL, Maruff P. Visual Memory Deficits in Middle-Aged APOEɛ4 Homozygotes Detected Using Unsupervised Cognitive Assessments. Journal of Alzheimer's Disease : Jad. PMID 33492293 DOI: 10.3233/JAD-201281  1
2021 Luckett PH, McCullough A, Gordon BA, Strain J, Flores S, Dincer A, McCarthy J, Kuffner T, Stern A, Meeker KL, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, ... ... Masters CL, et al. Modeling autosomal dominant Alzheimer's disease with machine learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33480178 DOI: 10.1002/alz.12259  1
2021 Smith R, Strain J, Tanenbaum A, Fagan A, Hassenstab J, Mcdade E, Schindler S, Gordon B, Xiong C, Chhatwal J, Jack CR, Karch C, Berman S, Brosch J, Lah J, ... ... Masters C, et al. Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease. Brain Connectivity. PMID 33430685 DOI: 10.1089/brain.2020.0808  1
2020 Alnakhli SH, Wand H, Law M, Sarros S, Stehmann C, Senesi M, Klug GM, Simpson M, Lewis V, Masters CL, Collins SJ. Corrigendum to "Intra-cerebral haemorrhage but not neurodegenerative disease appears over-represented in deaths of Australian cadaveric pituitary hormone recipients" [J. Clin. Neurosci. 81 (2020) 78-82]. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 81: 447. PMID 33602416 DOI: 10.1016/j.jocn.2020.10.026  1
2020 Dincer A, Gordon BA, Hari-Raj A, Keefe SJ, Flores S, McKay NS, Paulick AM, Shady Lewis KE, Feldman RL, Hornbeck RC, Allegri R, Ances BM, Berman SB, Brickman AM, Brooks WS, ... ... Masters CL, et al. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease. Neuroimage. Clinical. 28: 102491. PMID 33395982 DOI: 10.1016/j.nicl.2020.102491  1
2020 Lim YY, Laws SM, Perin S, Pietrzak RH, Fowler C, Masters CL, Maruff P. BDNF VAL66MET Polymorphism and Memory Decline Across the Spectrum of Alzheimer's Disease. Genes, Brain, and Behavior. e12724. PMID 33369083 DOI: 10.1111/gbb.12724  1
2020 Dehghani C, Frost S, Jayasena R, Fowler C, Masters CL, Kanagasingam Y, Jiao H, Lim JKH, Chinnery HR, Downie LE. Morphometric Changes to Corneal Dendritic Cells in Individuals With Mild Cognitive Impairment. Frontiers in Neuroscience. 14: 556137. PMID 33362451 DOI: 10.3389/fnins.2020.556137  1
2020 Chatterjee P, Fagan AM, Xiong C, McKay M, Bhatnagar A, Wu Y, Singh AK, Taddei K, Martins I, Gardener SL, Molloy MP, Multhaup G, Masters CL, Schofield PR, Benzinger TLS, et al. Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite Alterations. Journal of Alzheimer's Disease : Jad. PMID 33361604 DOI: 10.3233/JAD-201267  1
2020 Bourgeat P, Doré V, Doecke J, Ames D, Masters CL, Rowe CC, Fripp J, Villemagne VL. Non-negative matrix factorization improves Centiloid robustness in longitudinal studies. Neuroimage. 117593. PMID 33248259 DOI: 10.1016/j.neuroimage.2020.117593  1
2020 Alnakhli SH, Wand H, Law M, Sarros S, Stehmann C, Senesi M, Klug GM, Simpson M, Lewis V, Masters CL, Collins SJ. Intra-cerebral haemorrhage but not neurodegenerative disease appears over-represented in deaths of Australian cadaveric pituitary hormone recipients. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 81: 78-82. PMID 33222975 DOI: 10.1016/j.jocn.2020.09.021  1
2020 Huynh K, Lim WLF, Giles C, Jayawardana KS, Salim A, Mellett NA, Smith AAT, Olshansky G, Drew BG, Chatterjee P, Martins I, Laws SM, Bush AI, Rowe CC, Villemagne VL, ... ... Masters CL, et al. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease. Nature Communications. 11: 5698. PMID 33173055 DOI: 10.1038/s41467-020-19473-7  1
2020 Xia Y, Yassi N, Raniga P, Bourgeat P, Desmond P, Doecke J, Ames D, Laws SM, Fowler C, Rainey-Smith SR, Martins R, Maruff P, Villemagne VL, Masters CL, Rowe CC, et al. Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging. Journal of Alzheimer's Disease : Jad. PMID 32986666 DOI: 10.3233/JAD-200419  1
2020 Vermunt L, Dicks E, Wang G, Dincer A, Flores S, Keefe SJ, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Fox NC, Ghetti B, Graff-Radford NR, Hassenstab J, Karch CM, ... ... Masters CL, et al. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease. Brain Communications. 2: fcaa102. PMID 32954344 DOI: 10.1093/braincomms/fcaa102  1
2020 Burnham SC, Fandos N, Fowler C, Pérez-Grijalba V, Dore V, Doecke JD, Shishegar R, Cox T, Fripp J, Rowe C, Sarasa M, Masters CL, Pesini P, Villemagne VL. Longitudinal evaluation of the natural history of amyloid-β in plasma and brain. Brain Communications. 2: fcaa041. PMID 32954297 DOI: 10.1093/braincomms/fcaa041  1
2020 Lim YY, Maruff P, Kaneko N, Doecke J, Fowler C, Villemagne VL, Kato T, Rowe CC, Arahata Y, Iwamoto S, Ito K, Tanaka K, Yanagisawa K, Masters CL, Nakamura A. Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32925048 DOI: 10.3233/Jad-200475  1
2020 Cheng L, Vella LJ, Barnham KJ, McLean C, Masters CL, Hill AF. Small RNA fingerprinting of Alzheimer's disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles. Journal of Extracellular Vesicles. 9: 1766822. PMID 32922692 DOI: 10.1080/20013078.2020.1766822  1
2020 Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Erus G, Nasrallah I, Launer LJ, Rashid T, Bilgel M, Fan Y, Toledo JB, Yaffe K, Sotiras A, Srinivasan D, ... ... Masters C, et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32920988 DOI: 10.1002/Alz.12178  1
2020 Lim YY, Baker JE, Bruns L, Mills A, Fowler C, Fripp J, Rainey-Smith SR, Ames D, Masters CL, Maruff P. Association of deficits in short-term learning and Aβ and hippoampal volume in cognitively normal adults. Neurology. PMID 32887774 DOI: 10.1212/WNL.0000000000010728  1
2020 Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. PMID 32873693 DOI: 10.1212/Wnl.0000000000010747  1
2020 Siddiqui MS, Francois M, Rainey-Smith S, Martins R, Masters CL, Ames D, Rowe CC, Macaulay LS, Fenech MF, Leifert WR. Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing. Life (Basel, Switzerland). 10. PMID 32781776 DOI: 10.3390/Life10080141  1
2020 Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer's Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 32772959 DOI: 10.1017/S135561772000079X  1
2020 Burnham SC, Laws SM, Budgeon CA, Doré V, Porter T, Bourgeat P, Buckley RF, Murray K, Ellis KA, Turlach BA, Salvado O, Ames D, Martins RN, Rentz D, Masters CL, et al. Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition. Neurobiology of Aging. 95: 46-55. PMID 32750666 DOI: 10.1016/J.Neurobiolaging.2020.06.001  1
2020 Pedrini S, Hone E, Gupta VB, James I, Teimouri E, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Rainey-Smith S, Verdile G, Sohrabi HR, Raida MR, Wenk MR, et al. Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance. Journal of Alzheimer's Disease : Jad. PMID 32741823 DOI: 10.3233/Jad-200291  1
2020 Stehmann C, Senesi M, Sarros S, McGlade A, Simpson M, Klug G, McLean C, Masters CL, Collins S. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2019. Communicable Diseases Intelligence (2018). 44. PMID 32664829 DOI: 10.33321/Cdi.2020.44.56  1
2020 Bashyam VM, Erus G, Doshi J, Habes M, Nasralah I, Truelove-Hill M, Srinivasan D, Mamourian L, Pomponio R, Fan Y, Launer LJ, Masters CL, Maruff P, Zhuo C, Völzke H, et al. MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide. Brain : a Journal of Neurology. PMID 32591831 DOI: 10.1093/Brain/Awaa160  1
2020 Schindler SE, Jicha GA, Nelson PT, Keene CD, Blennow K, Molinuevo JL, Masters CL, Hansson O, Teunissen CE, Galasko D, Shaw LM, Levey AI. Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19. Journal of Alzheimer's Disease : Jad. PMID 32568212 DOI: 10.3233/JAD-200684  1
2020 Schultz SA, Strain JF, Adedokun A, Wang Q, Preische O, Kuhle J, Flores S, Keefe S, Dincer A, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal J, Cruchaga C, ... ... Masters C, et al. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. Neurobiology of Disease. 104960. PMID 32522711 DOI: 10.1016/J.Nbd.2020.104960  1
2020 Ashraf A, Ashton NJ, Chatterjee P, Goozee K, Shen K, Fripp J, Ames D, Rowe C, Masters CL, Villemagne V, Hye A, Martins RN, So PW. Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology. Alzheimer's Research & Therapy. 12: 72. PMID 32517787 DOI: 10.1186/S13195-020-00634-1  1
2020 Lim WLF, Huynh K, Chatterjee P, Martins I, Jayawardana KS, Giles C, Mellett NA, Laws SM, Bush AI, Rowe CC, Villemagne VL, Ames D, Drew BG, Masters CL, Meikle PJ, et al. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32474467 DOI: 10.3233/Jad-191304  1
2020 Masters CL. Major risk factors for Alzheimer's disease: age and genetics. The Lancet. Neurology. 19: 475-476. PMID 32470411 DOI: 10.1016/S1474-4422(20)30155-1  0.01
2020 Lim B, Li QX, Rowe C, Dhiman K, Gupta VB, Masters CL, Doecke JD, Martins RN, Collins S, Diamandis EP. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease. Neuroscience Letters. 135078. PMID 32450185 DOI: 10.1016/J.Neulet.2020.135078  1
2020 Wu HZY, Thalamuthu A, Cheng L, Fowler C, Masters CL, Sachdev P, Mather KA. Differential blood miRNA expression in brain amyloid imaging-defined Alzheimer's disease and controls. Alzheimer's Research & Therapy. 12: 59. PMID 32414413 DOI: 10.1186/S13195-020-00627-0  1
2020 Venkatraman VK, Steward CE, Cox KL, Ellis KA, Phal PM, Sharman MJ, Villemagne VL, Lai MMY, Cyarto EV, Ames D, Szoeke C, Rowe CC, Masters CL, Lautenschlager NT, Desmond PM. Baseline White Matter Is Associated With Physical Fitness Change in Preclinical Alzheimer's Disease. Frontiers in Aging Neuroscience. 12: 115. PMID 32410984 DOI: 10.3389/Fnagi.2020.00115  1
2020 Castillo-Barnes D, Su L, Ramírez J, Salas-Gonzalez D, Martinez-Murcia FJ, Illan IA, Segovia F, Ortiz A, Cruchaga C, Farlow MR, Xiong C, Graff-Radford NR, Schofield PR, Masters CL, Salloway S, et al. Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning. An International Journal On Information Fusion. 58: 153-167. PMID 32284705 DOI: 10.1016/J.Inffus.2020.01.001  1
2020 Panegyres PK, Stehmann C, Klug GM, Masters CL, Collins S. Prion disease in Indigenous Australians. Internal Medicine Journal. PMID 32237029 DOI: 10.1111/Imj.14835  1
2020 Doecke JD, Ward L, Burnham SC, Villemagne VL, Li QX, Collins S, Fowler CJ, Manuilova E, Widmann M, Rainey-Smith SR, Martins RN, Masters CL. Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging. Alzheimer's Research & Therapy. 12: 36. PMID 32234072 DOI: 10.1186/s13195-020-00595-5  1
2020 Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Hone E, Blennow K, et al. Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12005. PMID 32211500 DOI: 10.1002/Dad2.12005  1
2020 Doecke JD, Pérez-Grijalba V, Fandos N, Fowler C, Villemagne VL, Masters CL, Pesini P, Sarasa M. Total Aβ/Aβ ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis. Neurology. PMID 32179698 DOI: 10.1212/WNL.0000000000009240  1
2020 Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, ... ... Masters CL, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z  1
2020 Amadoru S, Doré V, McLean CA, Hinton F, Shepherd CE, Halliday GM, Leyton CE, Yates PA, Hodges JR, Masters CL, Villemagne VL, Rowe CC. Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease. Alzheimer's Research & Therapy. 12: 22. PMID 32131891 DOI: 10.1186/S13195-020-00587-5  1
2020 Franzmeier N, Koutsouleris N, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Duering M, Dichgans M, Levin J, Gordon BA, Lim YY, Masters CL, Rossor M, Fox NC, et al. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043733 DOI: 10.1002/Alz.12032  1
2020 Klatt S, Roberts A, Lothian A, Masters CL, Cappai R, Fowler C, Roberts BR. Optimizing red blood cell protein extraction for biomarker quantitation with mass spectrometry. Analytical and Bioanalytical Chemistry. PMID 32030493 DOI: 10.1007/s00216-020-02439-5  1
2020 Lai MMY, Sharman MJ, Ames DJ, Ellis KA, Cox KL, Hepworth G, Desmond P, Cyarto EV, Martins RN, Masters CL, Lautenschlager NT. Relationship of Established Cardiovascular Risk Factors and Peripheral Biomarkers on Cognitive Function in Adults at Risk of Cognitive Deterioration. Journal of Alzheimer's Disease : Jad. PMID 32007955 DOI: 10.3233/JAD-190953  1
2020 Aschenbrenner AJ, James BD, McDade E, Wang G, Lim YY, Benzinger TLS, Cruchaga C, Goate A, Xiong C, Perrin R, Buckles V, Allegri R, Berman SB, Chhatwal JP, Fagan A, ... ... Masters C, et al. Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 219-228. PMID 31914221 DOI: 10.1002/Alz.12010  1
2019 Dang C, Yassi N, Harrington KD, Xia Y, Lim YY, Ames D, Laws SM, Hickey M, Rainey-Smith S, Sohrabi HR, Doecke JD, Fripp J, Salvado O, Snyder PJ, Weinborn M, ... ... Masters CL, et al. Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 566-575. PMID 31909172 DOI: 10.1016/j.dadm.2019.05.005  1
2019 Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe C, Villemagne V, Salvado O, ... ... Masters CL, et al. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31884485 DOI: 10.3233/Jad-191028  1
2019 Eratne D, Loi SM, Li QX, Varghese S, McGlade A, Collins S, Masters CL, Velakoulis D, Walterfang M. Cerebrospinal fluid neurofilament light chain is elevated in Niemann-Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response. The Australian and New Zealand Journal of Psychiatry. 4867419893431. PMID 31823653 DOI: 10.1177/0004867419893431  1
2019 Pomponio R, Erus G, Habes M, Doshi J, Srinivasan D, Mamourian E, Bashyam V, Nasrallah IM, Satterthwaite TD, Fan Y, Launer LJ, Masters CL, Maruff P, Zhuo C, Völzke H, et al. Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan. Neuroimage. 116450. PMID 31821869 DOI: 10.1016/J.Neuroimage.2019.116450  1
2019 Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31759879 DOI: 10.1016/J.Jalz.2019.09.074  1
2019 Hata S, Omori C, Kimura A, Saito H, Kimura N, Gupta V, Pedrini S, Hone E, Chatterjee P, Taddei K, Kasuga K, Ikeuchi T, Waragai M, Nishimura M, Hu A, ... ... Masters CL, et al. Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 740-750. PMID 31754625 DOI: 10.1016/J.Trci.2019.09.015  1
2019 Vacher M, Porter T, Villemagne VL, Milicic L, Peretti M, Fowler C, Martins R, Rainey-Smith S, Ames D, Masters CL, Rowe CC, Doecke JD, Laws SM. Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition. Scientific Reports. 9: 17069. PMID 31745181 DOI: 10.1038/S41598-019-53604-5  1
2019 Tayebi M, El-Hage CM, Pinczowski P, Whiteley P, David M, Li QX, Varghese S, Mikhael M, Habiba U, Harman D, Tatarczuch L, Bogeski M, Birchall I, Ferguson K, Walker L, ... Masters C, et al. Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos. Scientific Reports. 9: 16546. PMID 31723225 DOI: 10.1038/s41598-019-53396-8  1
2019 Burnham SC, Coloma PM, Li QX, Collins S, Savage G, Laws S, Doecke J, Maruff P, Martins RN, Ames D, Rowe CC, Masters CL, Villemagne VL. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study. The Journal of Prevention of Alzheimer's Disease. 6: 248-255. PMID 31686097 DOI: 10.14283/jpad.2019.25  1
2019 Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 670-678. PMID 31673597 DOI: 10.1016/j.dadm.2019.08.004  1
2019 Dube U, Del-Aguila JL, Li Z, Budde JP, Jiang S, Hsu S, Ibanez L, Fernandez MV, Farias F, Norton J, Gentsch J, Wang F, Salloway S, Masters CL, et al. An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nature Neuroscience. PMID 31591557 DOI: 10.1038/S41593-019-0501-5  1
2019 Hadoux X, Hui F, Lim JKH, Masters CL, Pébay A, Chevalier S, Ha J, Loi S, Fowler CJ, Rowe C, Villemagne VL, Taylor EN, Fluke C, Soucy JP, Lesage F, et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease. Nature Communications. 10: 4227. PMID 31530809 DOI: 10.1038/S41467-019-12242-1  1
2019 Burnham SC, Loi SM, Doecke J, Fedyashov V, Dore V, Villemagne VL, Masters CL. The dawn of robust individualised risk models for dementia. The Lancet. Neurology. PMID 31526626 DOI: 10.1016/S1474-4422(19)30353-9  1
2019 Baker JE, Bruns L, Hassenstab J, Masters CL, Maruff P, Lim YY. Use of an experimental language acquisition paradigm for standardized neuropsychological assessment of learning: A pilot study in young and older adults. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 31514573 DOI: 10.1080/13803395.2019.1665626  1
2019 Huq AJ, Fransquet P, Laws SM, Ryan J, Sebra R, Masters CL, Winship IM, James PA, Lacaze P. Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506248 DOI: 10.1016/J.Jalz.2019.05.011  1
2019 Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, et al. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506247 DOI: 10.1016/J.Jalz.2019.06.4955  1
2019 Stehmann C, Senesi M, Lewis V, Ummi M, Simpson M, Klug G, McLean C, Masters C, Collins S. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2018. Communicable Diseases Intelligence (2018). 43. PMID 31426734 DOI: 10.33321/cdi.2019.43.35  1
2019 Baker JE, Pietrzak RH, Laws SM, Ames D, Villemagne VL, Rowe CC, Masters CL, Maruff P, Lim YY. Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults. Neuropsychology. PMID 31368758 DOI: 10.1037/neu0000561  1
2019 Venkatraman VK, Sanderson A, Cox KL, Ellis KA, Steward C, Phal PM, Gorelik A, Sharman MJ, Villemagne VL, Lai M, Cyarto EV, Merkel B, Ames D, Szoeke C, Rowe CC, ... Masters CL, et al. Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial. Neurobiology of Aging. PMID 31324405 DOI: 10.1016/J.Neurobiolaging.2019.02.030  1
2019 Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, Palmqvist S, Masters CL, Maruff PT, Hansson O, Mattsson N. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. PMID 31289148 DOI: 10.1212/Wnl.0000000000007831  1
2019 Eratne D, Loi SM, Walia N, Farrand S, Li QX, Varghese S, Walterfang M, Evans A, Mocellin R, Dhiman K, Gupta V, Malpas CB, Collins S, Masters CL, Velakoulis D. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists? The Australian and New Zealand Journal of Psychiatry. 4867419857811. PMID 31220922 DOI: 10.1177/0004867419857811  1
2019 Taswell C, Donohue C, Mastwyk MT, Louey AG, Giummarra J, Robertson J, Darby DG, Masters CL, Rowe CC. Avoiding methodological bias in studies of amyloid imaging results disclosure. Alzheimer's Research & Therapy. 11: 52. PMID 31159862 DOI: 10.1186/s13195-019-0495-y  1
2019 Fazlollahi A, Calamante F, Liang X, Bourgeat P, Raniga P, Dore V, Fripp J, Ames D, Masters CL, Rowe CC, Connelly A, Villemagne VL, Salvado O. Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease. Journal of Magnetic Resonance Imaging : Jmri. PMID 31145515 DOI: 10.1002/Jmri.26810  1
2019 Shaw LM, Hansson O, Manuilova E, Masters CL, Doecke JD, Li QX, Rutz S, Widmann M, Leinenbach A, Blennow K. Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS. Clinical Biochemistry. PMID 31129181 DOI: 10.1016/j.clinbiochem.2019.05.006  1
2019 Doré V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S. Comparison of F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL approaches: Validation against histopathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31101517 DOI: 10.1016/J.Jalz.2019.02.005  1
2019 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. val158met is not associated with Aβ-amyloid and ε4 related cognitive decline in cognitively normal older adults. Ibro Reports. 6: 147-152. PMID 31080907 DOI: 10.1016/J.Ibror.2019.05.001  1
2019 Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 1-10. PMID 30924399 DOI: 10.1080/13803395.2019.1593949  1
2019 Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, ... ... Masters CL, et al. The BDNF SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. Molecular Psychiatry. PMID 30899092 DOI: 10.1038/S41380-019-0404-6  1
2019 Vöglein J, Paumier K, Jucker M, Preische O, McDade E, Hassenstab J, Benzinger TL, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, Farlow MR, Chhatwal J, Salloway S, Xiong C, ... ... Masters CL, et al. Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30897203 DOI: 10.1093/Brain/Awz050  1
2019 Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Jack CR, Farlow MR, Salloway S, Snider BJ, Berman SB, ... ... Masters CL, et al. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 180-190. PMID 30847382 DOI: 10.1016/J.Dadm.2018.12.008  1
2019 Soldan A, Pettigrew C, Fagan AM, Schindler SE, Moghekar A, Fowler C, Li QX, Collins SJ, Carlsson C, Asthana S, Masters CL, Johnson S, Morris JC, Albert M, Gross AL. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. PMID 30842300 DOI: 10.1212/Wnl.0000000000007248  1
2019 Buckley RF, Waller M, Masters CL, Dobson A. To What Extent Does Age at Death Account for Sex Differences in Alzheimer's Disease Mortality Rates? American Journal of Epidemiology. PMID 30824901 DOI: 10.1093/aje/kwz048  1
2019 Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, ... ... Masters CL, et al. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease. Science Advances. 5: eaau7220. PMID 30775436 DOI: 10.1126/Sciadv.Aau7220  1
2019 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, et al. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 76: 162-165. PMID 30716541 DOI: 10.1016/J.Neurobiolaging.2018.12.014  1
2019 Villemagne VL, Velakoulis D, Doré V, Bozinoski S, Masters CL, Rowe CC, Walterfang M. Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30690666 DOI: 10.1007/s00259-019-4273-7  1
2019 Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nature Medicine. PMID 30664784 DOI: 10.1038/S41591-018-0304-3  1
2019 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Peretti M, Sohrabi HR, Lim YYY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith SR, Rowe C, Salvado O, et al. P4-485: SPON1 is associated with Aβ-Amyloid and APOE ε4 related cognitive decline in cognitively normal adults Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.08.031  1
2019 Rowe CC, Dore V, Mulligan RS, Tyrrell R, Guzman R, Lamb F, Bourgeat P, Fripp J, Masters CL, Villemagne VL. O5‐01‐05: Tau Imaging With 18F‐Mk6240 In Alzheimer'S Disease And Other Dementias Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4838  1
2019 Villemagne VL, Burnham SC, Bourgeat P, Dore V, Laws SM, Fripp J, Martins RN, Masters CL, Rowe CC. ASSESSING GLOBAL AND REGIONAL Aβ-AMYLOID DEPOSITION IN THE BRAIN WITH MULTIPLE Aβ-TRACERS USING THE CENTILOID SCALE Alzheimers & Dementia. 15: 219. DOI: 10.1016/J.Jalz.2019.06.4571  1
2019 Burnham SC, Fandos N, Fowler C, Pérez-Grijalba V, Dore V, Doecke JD, Sarasa M, Fripp J, Rowe C, Masters CL, Pesini P, Villemagne VL. LONGITUDINAL EVALUATION OF THE NATURAL HISTORY OF Aβ IN PLASMA AND BRAIN Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4553  1
2019 Kall LMvD, Burnham SC, Dore V, Mulligan RS, Bozinovski S, Bourgeat P, Tyrrell R, Young K, Fripp J, Masters CL, Villemagne VL, Rowe C. Ic-P-017: Amyloid Pet Is More Than Just Positive Or Negative: Amyloid Level Impacts Risk Of Clinical Progression In Normal Individuals Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4179  1
2019 Bourgeat P, Dore V, Williams S, Ames D, Masters CL, Fripp J, Rowe CC, Villemagne VL. Ic-P-004: Correcting For Pet Scanner Changes In Longitudinal Studies Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3094  1
2019 Rowe CC, Dean B, Ackermann U, Goh R, Guzman R, Kanaan R, Chong L, Dore V, Bozinovski S, Masters CL, Villemagne VL. P2-390: In Vivo Imaging Of Brain Muscarinic Receptors With 18F-Flurobenzyl Dexetimide: First In Human Studies Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2797  1
2018 Klug GM, Sarros S, Stehmann C, Simpson M, McLean C, Masters CL, Collins SJ. Creutzfeldt-Jakob disease surveillance in Australia: update to December 2016. Communicable Diseases Intelligence (2018). 42. PMID 30626302  1
2018 Porter T, Burnham SC, Savage G, Lim YY, Maruff P, Milicic L, Peretti M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Taddei K, Groth D, et al. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 423. PMID 30620773 DOI: 10.3389/Fnagi.2018.00423  1
2018 Vöglein J, Noachtar S, McDade E, Quaid KA, Salloway S, Ghetti B, Noble J, Berman S, Chhatwal J, Mori H, Fox N, Allegri R, Masters CL, Buckles V, Ringman JM, et al. Seizures as an early symptom of autosomal dominant Alzheimer's disease. Neurobiology of Aging. 76: 18-23. PMID 30616208 DOI: 10.1016/J.Neurobiolaging.2018.11.022  1
2018 Suárez-Calvet M, Capell A, Araque Caballero MÁ, Morenas-Rodríguez E, Fellerer K, Franzmeier N, Kleinberger G, Eren E, Deming Y, Piccio L, Karch CM, Cruchaga C, Paumier K, Bateman RJ, Fagan AM, ... ... Masters CL, et al. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. Embo Molecular Medicine. PMID 30482868 DOI: 10.15252/Emmm.201809712  1
2018 Lothian A, Lago L, Mukherjee S, Connor AR, Fowler C, McLean CA, Horne M, Masters CL, Cappai R, Roberts BR. Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn. Metallomics : Integrated Biometal Science. PMID 30465671 DOI: 10.1039/C8Mt00223A  1
2018 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Li QX, Ames D, Masters CL, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, et al. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. Journal of Alzheimer's Disease : Jad. PMID 30412495 DOI: 10.3233/Jad-180713  1
2018 Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, Taddei K, Laws SM, Sohrabi HR, Weinborn M, Ames D, Fowler C, Macaulay SL, Maruff P, Masters CL, et al. Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Translational Psychiatry. 8: 238. PMID 30375373 DOI: 10.1038/S41398-018-0293-5  1
2018 Cox KL, Cyarto EV, Ellis KA, Ames D, Desmond P, Phal P, Sharman MJ, Szoeke C, Rowe CC, Masters CL, You E, Burrows S, Lai MMY, Lautenschlager NT. A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study. Journal of Alzheimer's Disease : Jad. PMID 30372680 DOI: 10.3233/JAD-180521  1
2018 Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C, Jagust WJ, Jin LW, Klunk WE, ... ... Masters CL, et al. Multisite study of the relationships between antemortem [C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30347188 DOI: 10.1016/J.Jalz.2018.09.001  1
2018 Hampel H, O'Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews. Neurology. PMID 30297701 DOI: 10.1038/S41582-018-0079-7  1
2018 Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith SR, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, ... Masters CL, et al. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 30272115 DOI: 10.1093/Arclin/Acy078  1
2018 Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Fox NN, Graff-Radford NR, Levin J, Danek A, ... ... Masters CL, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30266303 DOI: 10.1016/J.Jalz.2018.06.3059  1
2018 Araque Caballero MÁ, Suárez-Calvet M, Duering M, Franzmeier N, Benzinger T, Fagan AM, Bateman RJ, Jack CR, Levin J, Dichgans M, Jucker M, Karch C, Masters CL, Morris JC, Weiner M, et al. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30239611 DOI: 10.1093/Brain/Awy229  1
2018 McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, ... ... Masters C, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. PMID 30217935 DOI: 10.1212/Wnl.0000000000006277  1
2018 Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith S, Robertson J, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Rowe CC, ... Masters CL, et al. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 30149452 DOI: 10.3233/Jad-180507  1
2018 Bourgeat P, Doré V, Fripp J, Ames D, Masters CL, Salvado O, Villemagne VL, Rowe CC. Implementing the centiloid transformation for C-PiB and β-amyloid F-PET tracers using CapAIBL. Neuroimage. PMID 30130643 DOI: 10.1016/j.neuroimage.2018.08.044  1
2018 Dehghani C, Frost S, Jayasena R, Masters CL, Kanagasingam Y. Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions. Investigative Ophthalmology & Visual Science. 59: 3554-3563. PMID 30025102 DOI: 10.1167/Iovs.18-24694  1
2018 Harrington KD, Schembri A, Lim YY, Dang C, Ames D, Hassenstab J, Laws SM, Rainey-Smith S, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, et al. Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease. Neurobiology of Aging. 70: 170-179. PMID 30015036 DOI: 10.1016/J.Neurobiolaging.2018.06.005  1
2018 Lim YY, Hassenstab J, Goate A, Fagan AM, Benzinger TLS, Cruchaga C, McDade E, Chhatwal J, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, Salloway S, Schofield P, et al. Effect of BDNFVal66Met on disease markers in dominantly inherited AD. Annals of Neurology. PMID 30014553 DOI: 10.1002/Ana.25299  1
2018 Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. Nature Reviews. Neurology. PMID 29880829 DOI: 10.1038/s41582-018-0021-z  1
2018 Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, et al. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29803541 DOI: 10.1016/J.Jalz.2018.04.010  1
2018 Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, ... Masters CL, et al. Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study. Psychological Assessment. PMID 29781669 DOI: 10.1037/pas0000565  1
2018 Brown BM, Rainey-Smith SR, Dore V, Peiffer JJ, Burnham SC, Laws SM, Taddei K, Ames D, Masters CL, Rowe CC, Martins RN, Villemagne VL. Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 29758940 DOI: 10.3233/JAD-170998  1
2018 Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Masters CL, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. Plos One. 13: e0195838. PMID 29742105 DOI: 10.1371/Journal.Pone.0195838  1
2018 Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, ... ... Masters CL, et al. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease : Jad. 62: 965-992. PMID 29562546 DOI: 10.3233/Jad-171145  1
2018 Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years. Alzheimer Disease and Associated Disorders. PMID 29561277 DOI: 10.1097/WAD.0000000000000252  1
2018 Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, ... ... Masters CL, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain : a Journal of Neurology. PMID 29522171 DOI: 10.1093/Brain/Awy053  1
2018 Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, et al. Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden. Translational Psychiatry. 8: 47. PMID 29479071 DOI: 10.1038/s41398-018-0094-x  1
2018 Franzmeier N, Düzel E, Jessen F, Buerger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, et al. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease. Brain : a Journal of Neurology. PMID 29462334 DOI: 10.1093/Brain/Awy008  1
2018 Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. Nature Reviews. Neurology. PMID 29449700 DOI: 10.1038/nrneurol.2018.9  1
2018 Li QX, Varghese S, Sarros S, Stehmann C, Doecke JD, Fowler CJ, Masters CL, Collins SJ. CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnostics. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29422367 DOI: 10.1016/j.jocn.2018.01.064  1
2018 Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, ... ... Masters CL, et al. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature. 554: 249-254. PMID 29420472 DOI: 10.1038/Nature25456  1
2018 Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR, ... ... Masters CL, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. The Lancet. Neurology. PMID 29397305 DOI: 10.1016/S1474-4422(18)30028-0  1
2018 Porter T, Burnham SC, Doré V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, et al. KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden. Scientific Reports. 8: 2034. PMID 29391469 DOI: 10.1038/S41598-018-20513-Y  1
2018 Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, ... ... Masters CL, et al. Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β. Journal of Alzheimer's Disease : Jad. 61: 1589-1598. PMID 29376865 DOI: 10.3233/JAD-170742  1
2018 Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease. Jama Neurology. PMID 29356823 DOI: 10.1001/jamaneurol.2017.4325  1
2018 Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P, et al. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease. Journal of Affective Disorders. 229: 269-274. PMID 29329059 DOI: 10.1016/j.jad.2017.12.101  1
2018 Fazlollahi A, Calamante F, Liang X, Bourgeat P, Dore V, Raniga P, Fripp J, Ames D, Masters CL, Rowe C, Connelly A, Villemagne VL, Salvado O, (Aibl) L. P1-440: Increased Cerebral Blood Flow With Increased Amyloid Burden In Preclinical Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.449  1
2018 Burnham SC, Bourgeat P, Budgeon CA, Dore V, Savage G, Laws SM, Salvado O, Maruff P, Martins RN, Ames D, Sperling RA, Masters CL, Rowe CC, Villemagne VL. O4-09-01: COMPARISON OF THE NATURAL HISTORY OF NEOCORTICAL Aβ-AMYLOID, HIPPOCAMPAL VOLUME AND PACC IN SPORADIC AD Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2957  1
2018 Rowe CC, Amadoru S, Dore V, McLean C, Hinton F, Shepherd C, Halliday GM, Leyton CE, Hodges JR, Masters CL, Villemagne VL. O2-06-05: Correlation Of Amyloid Pet Expressed In Centiloid Units With Neuropathological Findings In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2673  1
2017 Pietrzak RH, Laws SM, Lim YY, Bender SJ, Porter T, Doecke J, Ames D, Fowler C, Masters CL, Milicic L, Rainey-Smith S, Villemagne VL, Rowe CC, Martins RN, Maruff P, et al. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 45-52. PMID 29560886 DOI: 10.1016/j.bpsc.2016.08.006  1
2017 Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Bozinosvski S, Salvado O, Bourgeat P, Perez K, Fowler C, Rembach A, Maruff P, Ritchie C, Tanzi R, Masters CL. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study. Alzheimer's & Dementia (New York, N. Y.). 3: 622-635. PMID 29201996 DOI: 10.1016/J.Trci.2017.10.001  1
2017 Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, ... ... Masters CL, et al. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms. Journal of Alzheimer's Disease : Jad. PMID 29171991 DOI: 10.3233/Jad-170128  1
2017 Pedrini S, Gupta VB, Hone E, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Scientific Reports. 7: 14057. PMID 29070909 DOI: 10.1038/S41598-017-14020-9  1
2017 Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain. Nature Reviews. Neurology. PMID 29027541 DOI: 10.1038/Nrneurol.2017.147  1
2017 Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain. Nature Reviews. Neurology. 13: 612-623. PMID 28960209 DOI: 10.1038/Nrneurol.2017.111  1
2017 Fandos N, Pérez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, Doecke J, Fowler C, Masters CL, Sarasa M. Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 179-187. PMID 28948206 DOI: 10.1016/j.dadm.2017.07.004  1
2017 Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, et al. Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline. Brain : a Journal of Neurology. 140: 2112-2119. PMID 28899019 DOI: 10.1093/Brain/Awx137  1
2017 Frost S, Robinson L, Rowe CC, Ames D, Masters CL, Taddei K, Rainey-Smith SR, Martins RN, Kanagasingam Y. Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry. Journal of Ophthalmology. 2017: 7935406. PMID 28894607 DOI: 10.1155/2017/7935406  1
2017 Laws SM, Gaskin S, Woodfield A, Srikanth V, Bruce D, Fraser PE, Porter T, Newsholme P, Wijesekara N, Burnham S, Doré V, Li QX, Maruff P, Masters CL, Rainey-Smith S, et al. Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. Scientific Reports. 7: 9766. PMID 28852028 DOI: 10.1016/J.Jalz.2017.06.2000  1
2017 Vella LJ, Scicluna BJ, Cheng L, Bawden EG, Masters CL, Ang CS, Willamson N, McLean C, Barnham KJ, Hill AF. A rigorous method to enrich for exosomes from brain tissue. Journal of Extracellular Vesicles. 6: 1348885. PMID 28804598 DOI: 10.1080/20013078.2017.1348885  1
2017 Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Doré V, Villemagne VL, Snyder PJ, Masters CL, Maruff P. Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 156-164. PMID 28761926 DOI: 10.1016/J.Dadm.2017.05.006  1
2017 Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway S, ... ... Masters CL, et al. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28738187 DOI: 10.1016/J.Jalz.2017.06.2268  1
2017 Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Fowler C, Ellis K, Martins RN, Salvado O, Doré V, Villemagne VL, Rowe CC, Laws SM, Masters CL, et al. Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study. International Journal of Geriatric Psychiatry. PMID 28736899 DOI: 10.1002/Gps.4761  1
2017 Lim YY, Rainey-Smith S, Lim Y, Laws SM, Gupta V, Porter T, Bourgeat P, Ames D, Fowler C, Salvado O, Villemagne VL, Rowe CC, Masters CL, Zhou XF, Martins RN, et al. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF. International Psychogeriatrics. 1-10. PMID 28720165 DOI: 10.1017/S1041610217001284  1
2017 Lu R, Wang J, Tao R, Wang J, Zhu T, Guo W, Sun Y, Li H, Gao Y, Zhang W, Fowler CJ, Li Q, Chen S, Wu Z, Masters CL, et al. Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment. Molecular Psychiatry. PMID 28696436 DOI: 10.1038/Mp.2017.136  1
2017 Finkelstein DI, Billings JL, Adlard PA, Ayton S, Sedjahtera A, Masters CL, Wilkins S, Shackleford DM, Charman SA, Bal W, Zawisza IA, Kurowska E, Gundlach AL, Ma S, Bush AI, et al. The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. Acta Neuropathologica Communications. 5: 53. PMID 28659169 DOI: 10.1186/S40478-017-0456-2  1
2017 Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS. A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 147-155. PMID 28653035 DOI: 10.1016/J.Dadm.2017.05.003  1
2017 Rowe CC, Doré V, Jones G, Baxendale D, Mulligan RS, Bullich S, Stephens AW, De Santi S, Masters CL, Dinkelborg L, Villemagne VL. (18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28643043 DOI: 10.1007/S00259-017-3749-6  1
2017 Lim YY, Williamson R, Laws SM, Villemagne VL, Bourgeat P, Fowler C, Rainey-Smith S, Salvado O, Martins RN, Rowe CC, Masters CL, Maruff P. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals. Journal of Alzheimer's Disease : Jad. PMID 28550258 DOI: 10.3233/JAD-170072  1
2017 Gupta VB, Hone E, Pedrini S, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 60-72. PMID 28508031 DOI: 10.1016/J.Dadm.2017.04.003  1
2017 Brown BM, Sohrabi HR, Taddei K, Gardener SL, Rainey-Smith SR, Peiffer JJ, Xiong C, Fagan AM, Benzinger T, Buckles V, Erickson KI, Clarnette R, Shah T, Masters CL, Weiner M, et al. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28501451 DOI: 10.1016/J.Jalz.2017.03.008  1
2017 Rita Cardoso B, Hare DJ, Lind M, McLean CA, Volitakis I, Laws SM, Masters CL, Bush AI, Roberts BR. The APOE ε4 allele is associated with lower selenium levels in the brain: implications in Alzheimer's disease. Acs Chemical Neuroscience. PMID 28453930 DOI: 10.1021/Acschemneuro.7B00014  1
2017 Mukherjee S, Kapp EA, Lothian A, Roberts AM, Vasilev Y, Boughton B, Barnham KJ, Kok WM, Hutton CA, Masters CL, Bush A, Beckman JS, Dey SG, Roberts BR. Characterization and identification of dityrosine cross-linked peptides using tandem mass spectrometry. Analytical Chemistry. PMID 28453255 DOI: 10.1021/Acs.Analchem.7B00941  1
2017 Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, ... ... Masters CL, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Scientific Reports. 7: 1225. PMID 28450713 DOI: 10.1038/S41598-017-01327-W  1
2017 Gardener SL, Rainey-Smith SR, Sohrabi HR, Weinborn M, Verdile G, Fernando WM, Lim YY, Harrington K, Burnham S, Taddei K, Masters CL, Macaulay SL, Rowe CC, Ames D, Maruff P, et al. Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner. Journal of Alzheimer's Disease : Jad. PMID 28387666 DOI: 10.3233/Jad-161158  1
2017 Roberts BR, Lind M, Wagen AZ, Rembach A, Frugier T, Li QX, Ryan TM, McLean CA, Doecke JD, Rowe CC, Villemagne VL, Masters CL. Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET. Brain : a Journal of Neurology. PMID 28383676 DOI: 10.1093/Brain/Awx057  1
2017 Butcher NJ, Horne MK, Mellick GD, Fowler CJ, Masters CL, Minchin RF. Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease. The Pharmacogenomics Journal. PMID 28374858 DOI: 10.1038/tpj.2017.4  1
2017 Frost S, Bhuiyan A, Offerman D, Doecke JD, Macaulay SL, Sohrabi HR, Ames D, Masters C, Martins RN, Kanagasingam Y, Aibl Research Group. Modulation of Retinal Arteriolar Central Reflection by APOE genotype. Current Alzheimer Research. PMID 28290247 DOI: 10.2174/1567205014666170309115016  1
2017 Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, Maruff P. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 108-121. PMID 28239636 DOI: 10.1016/J.Dadm.2016.09.002  1
2017 Hollands S, Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Harrington K, Porter T, Snyder P, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Rowe CC, ... Masters CL, et al. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 28234254 DOI: 10.3233/Jad-161019  1
2017 Cardoso BR, Hare DJ, Bush AI, Li QX, Fowler CJ, Masters CL, Martins RN, Ganio K, Lothian A, Mukherjee S, Kapp EA, Roberts BR. Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL). Journal of Alzheimer's Disease : Jad. PMID 28222503 DOI: 10.3233/Jad-160622  1
2017 Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, ... ... Masters CL, et al. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 56: 1159-1174. PMID 28157104 DOI: 10.3233/Jad-161097  0.72
2017 Peters KE, Davis WA, Taddei K, Martins RN, Masters CL, Davis TM, Bruce DG. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study. Journal of Alzheimer's Disease : Jad. PMID 28106562 DOI: 10.3233/Jad-161050  1
2017 Villemagne VL, Doré V, Bourgeat P, Burnham SC, Laws S, Salvado O, Masters CL, Rowe CC. Aβ-amyloid and Tau Imaging in Dementia. Seminars in Nuclear Medicine. 47: 75-88. PMID 27987560 DOI: 10.1053/j.semnuclmed.2016.09.006  1
2017 Villemagne VL, Burnham S, Bourgeat P, Dore V, Rainey-Smith SR, Laws SM, Brown BM, Maruff P, Savage G, Ames D, Salvado O, Martins RN, Masters CL, Rowe CC. REFINING THE NATURAL HISTORY OF GLOBAL AND REGIONAL Aβ-AMYLOID DEPOSITION IN SPORADIC ALZHEIMER’S DISEASE Alzheimers & Dementia. 13: 1530. DOI: 10.1016/J.Jalz.2017.07.661  1
2017 Burnham S, Bourgeat P, Dore V, Laws SM, Salvado O, Li Q, Masters CL, Rowe CC, Villemagne VL. Implementing The Atn Classification In Aibl Alzheimers & Dementia. 13: 1511. DOI: 10.1016/J.Jalz.2017.07.626  1
2017 Burnham S, Laws SM, Budgeon CA, Dore V, Bourgeat P, Porter T, Salvado O, Masters CL, Rowe CC, Villemagne VL. THE IMPACT OF APOE ε4 CARRIAGE ON Aβ-AMYLOID DEPOSITION IN AIBL Alzheimers & Dementia. 13: 1510. DOI: 10.1016/J.Jalz.2017.07.625  1
2017 Sohrabi HR, Gardener SL, Weinborn M, Shen K, Rainey-Smith SR, Brown BM, Taddei K, Doecke JD, Salvado O, Villemagne VLL, Maruff P, Savage G, Ames D, Masters CL, Rowe CC, et al. Cognitive Super-Aging Versus Typical Aging In Community-Dwelling Older Adults: Longitudinal Trajectories In Global Cortical Thickness Over Six Years Alzheimers & Dementia. 13: 1463. DOI: 10.1016/J.Jalz.2017.07.531  1
2017 Yates PA, Villemagne VLL, Dore V, Burnham S, Martins RN, Rainey-Smith SR, Salvado O, Ames D, Masters CL, Rowe CC. VASCULAR RISK MEASURES AND LONGITUDINAL Aβ ACCUMULATION: RESULTS FROM THE AIBL STUDY OF AGEING Alzheimers & Dementia. 13: 1238. DOI: 10.1016/J.Jalz.2017.07.441  1
2017 Doecke JD, Li QX, Fowler C, Collins S, Dore V, Rowe CC, Masters CL, Salvado O, Villemagne VL. CSF P-TAU IS CORRELATED WITH TAU PET, WHILE Aβ PET CORRELATES WITH Aβ1-42 AND THE T-TAU/Aβ1-42 RATIO Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.067  1
2017 Hanseeuw BJ, McDade E, Schultz AP, Martins RN, Schofield PR, Masters CL, Graff-Radford NR, Salloway S, Danek A, Levin J, Buckles V, Goate AM, Benzinger TL, Morris JC, Bateman RJ, et al. GENOTYPIC VARIANCE MAY EXPLAIN THE BALANCE OF EARLY CORTICAL VERSUS STRIATAL AMYLOID DEPOSITION IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P187-P188. DOI: 10.1016/J.Jalz.2017.07.043  1
2017 Song X, Dhindsa N, Rainey-Smith SR, Guo H, Zeng A, Brown BM, Ames D, Masters CL, Salvado O, Rowe CC, D'Arcy RCN, Martins RN, Rockwood K. Education And Physical Activity In Relation To Frailty And Whole-Brain Structural Health In Alzheimer'S Disease, Mild Cognitive Impairment, And Normal Aging: Results From The Australian Imaging, Biomarkers And Lifestyle Flagship Study Of Ageing (Aibl) Alzheimers & Dementia. 13: 639. DOI: 10.1016/J.Jalz.2017.06.735  1
2017 Brown BM, Rainey-Smith SR, Dore V, Peiffer JJ, Laws SM, Taddei K, Ames D, Masters CL, Rowe CC, Martins RN, Villemagne VL. Self-Reported Physical Activity Is Associated With Tau Burden As Measured By Pet Alzheimers & Dementia. 13: 528. DOI: 10.1016/J.Jalz.2017.06.623  1
2017 Fazlollahi A, Ayton S, Diouf I, Bourgeat P, Raniga P, Dore V, Ng A, Fripp J, Ames D, Masters CL, Rowe CC, Villemagne VL, Bush AI, Salvado O. QUANTITATIVE SUSCEPTIBILITY MAPPING OF THE HIPPOCAMPUS PREDICTS HIPPOCAMPAL ATROPHY IN Aβ+ ELDERLY CONTROLS AND ALZHEIMER’S DISEASE PATIENTS Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.460  1
2017 Doecke JD, Li Q, Bourgeat P, Fowler C, Collins S, Varghese S, Dore V, Rowe CC, Masters CL, Villemagne VL, Salvado O. Csf Total Tau As A Biomarker For Neuronal Injury In Alzheimer’S Disease: Aligning Rates Of Csf Change With Rates Of Hippocampal And Cortical Gray Matter Atrophy Alzheimers & Dementia. 13: 436. DOI: 10.1016/J.Jalz.2017.06.432  1
2017 Lim YY, Hassenstab J, Cruchaga C, Goate AM, Fagan AM, Benzinger TLS, Maruff P, Masters CL, McDade E, Morris JC, Bateman RJ. Bdnf Val66Met Increases Rate Of Memory Decline, Hippocampal Volume Loss And Tau Accumulation In Autosomal Dominant Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.283  1
2017 Cummins TL, Elias A, Hopwood M, Rosenfeld JV, Dore V, Lamb F, Williams R, Guzman R, Salvado O, Masters CL, Villemagne VL, Rowe CC. TAU, Aβ-AMYLOID, AND COGNITIVE FUNCTION FOLLOWING SERVICE-RELATED TRAUMATIC BRAIN INJURY IN VIETNAM WAR VETERANS Alzheimers & Dementia. 13: 101. DOI: 10.1016/J.Jalz.2017.06.2408  1
2017 Yassi N, Hilal S, Lim YY, Salinas S, Kuijf H, Xia Y, Chen C, Salvado O, Rowe CC, Desmond P, Masters CL. Cortical Cerebral Microinfarcts On 3T Mri In Alzheimer’S Disease And Mild Cognitive Impairment Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2124  1
2017 Pedrini S, Gupta VB, Hone E, Doecke JD, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VLL, Ames D, Masters CL, Martins RN. IL-10 AND IL-12/23P40 ARE JOINTLY ASSOCIATED AS PREDICTORS OF Aβ-AMYLOID LOAD IN A BROADER BLOOD-BASED BIOMARKER PANEL Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2002  1
2017 Harrington KD, Schembri A, Lim YY, Ames D, Rainey-Smith SR, Salvado O, Villemagne VLL, Rowe CC, Masters CL, Maruff P. CONSIDERATION OF PRECLINICAL AD FROM THE PERSPECTIVE OF NORMAL AGING: AMYLOID-β RELATED CHANGES IN FLUID AND CRYSTALLIZED INTELLIGENCE IN A ROBUST SAMPLE OF HEALTHY OLDER ADULTS Alzheimers & Dementia. 13: 1150. DOI: 10.1016/J.Jalz.2017.06.1680  1
2017 Hearn N, Dore V, Fripp J, Grothe MJ, Teipel SJ, Masters CL, Rowe CC, Coulson E, Villemagne VLL. Global tau burden correlates with basal forebrain atrophy in healthy aging subjects Alzheimers & Dementia. 13: 1089. DOI: 10.1016/J.Jalz.2017.06.1565  1
2017 Bourgeat P, Villemagne VLL, Dore V, Masters CL, Ames D, Rowe CC, Salvado O, Fripp J. 18F-Av1451 Tau Quantification Without Mri Alzheimers & Dementia. 13: 1074. DOI: 10.1016/J.Jalz.2017.06.1540  1
2017 Ashton NJ, Narvardo-Holgado AJ, Lynham S, Ward M, Gupta VB, Chatterjee P, Goozee K, Hone E, Pedrini S, Bush AI, Rowe CC, Villemagne VLL, Ames D, Masters CL, Aarsland D, et al. A mass spectrometry-based discovery and replication of a multi-analyte classifier for neocortical amyloid pathology Alzheimers & Dementia. 13: 1033. DOI: 10.1016/J.Jalz.2017.06.1456  1
2017 Hone E, Pedrini S, Gupta VB, Russell A, Laws SM, Villemagne VLL, Rowe CC, Ames D, Masters CL, Martins RN. The Influence Of Low-Density Lipoproteins On Neocortical Amyloid Load In The Australian Imaging Biomarker And Lifestyle Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1437  1
2017 Rowe CC, Dore V, Bourgeat P, Williams R, Ames D, Salvado O, Masters CL, Villemagne VLL. LONGITUDINAL ASSESSMENT OF Aβ ACCUMULATION WITH FLUTEMETAMOL Alzheimers & Dementia. 13: 778. DOI: 10.1016/J.Jalz.2017.06.1044  1
2017 Villemagne VLL, Velakoulis D, Dore V, Bozinovski S, Masters CL, Rowe CC, Waterfang M. TAU AND Aβ-AMYLOID IMAGING IN NIEMANN-PICK TYPE C Alzheimers & Dementia. 13: 756. DOI: 10.1016/J.Jalz.2017.06.1003  1
2016 Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ. Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015. Communicable Diseases Intelligence Quarterly Report. 40: E368-E376. PMID 28278413  1
2016 Sabbagh MN, Schäuble B, Anand K, Richards D, Murayama S, Akatsu H, Takao M, Rowe CC, Masters CL, Barthel H, Gertz HJ, Peters O, Rasgon N, Jovalekic A, Sabri O, et al. Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27983552 DOI: 10.3233/Jad-160821  1
2016 Harrington KD, Lim YY, Ames D, Hassenstab J, Rainey-Smith S, Robertson J, Salvado O, Masters CL, Maruff P. Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 27932344 DOI: 10.1093/Arclin/Acw106  1
2016 Roberts BR, Doecke JD, Rembach A, Yévenes LF, Fowler CJ, McLean CA, Lind M, Volitakis I, Masters CL, Bush AI, Hare DJ. Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid. Acta Neuropathologica Communications. 4: 119. PMID 27842602 DOI: 10.1186/S40478-016-0390-8  1
2016 Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, ... ... Masters CL, et al. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 27777020 DOI: 10.1016/S1474-4422(16)30229-0  1
2016 Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Martins RN, Salvado O, Dore V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Maruff P, Pietrzak RH, et al. β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27742526 DOI: 10.1016/J.Jagp.2016.08.007  1
2016 Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, ... ... Masters CL, et al. Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. Plos One. 11: e0163669. PMID 27649320 DOI: 10.1371/journal.pone.0163669  1
2016 Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Corrigendum: Corrigendum to 'Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment'. Age and Ageing. 45: 742. PMID 27646269 DOI: 10.1093/Ageing/Afw117  1
2016 Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Bourgeat P, Martins RN, Salvado O, Rowe CC, Masters CL, Maruff P. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia. Journal of Molecular Neuroscience : Mn. PMID 27586003 DOI: 10.1007/s12031-016-0822-8  1
2016 Cerin E, Rainey-Smith SR, Ames D, Lautenschlager NT, Macaulay SL, Fowler C, Robertson JS, Rowe CC, Maruff P, Martins RN, Masters CL, Ellis KA. Associations of neighborhood environment with brain imaging outcomes in the AIBL cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27546307 DOI: 10.1016/j.jalz.2016.06.2364  1
2016 Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN, Maruff P, Macaulay SL, Rainey-Smith S, Savage G, Ames D, Masters CL, Wilson W, et al. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up. Neurology. PMID 27534714 DOI: 10.1212/Wnl.0000000000003094  1
2016 Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean C, Masters CL, Collins SJ. Creutzfeldt-Jakob disease surveillance in Australia: update to December 2014. Communicable Diseases Intelligence Quarterly Report. 40: E207-15. PMID 27522131  1
2016 Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, et al. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 27521573 DOI: 10.1093/Brain/Aww200  1
2016 Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson K, Sperling R, Amariglio R. A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease. Journal of Molecular Neuroscience : Mn. PMID 27514526 DOI: 10.1007/S12031-016-0810-Z  1
2016 Heffernan AL, Chidgey C, Peng P, Masters CL, Roberts BR. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts. Journal of Molecular Neuroscience : Mn. PMID 27498201 DOI: 10.1007/s12031-016-0804-x  1
2016 Burnham SC, Bourgeat P, Doré V, Savage G, Brown B, Laws S, Maruff P, Salvado O, Ames D, Martins RN, Masters CL, Rowe CC, Villemagne VL. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study. The Lancet. Neurology. PMID 27450471 DOI: 10.1016/S1474-4422(16)30125-9  1
2016 Yassi N, Desmond PM, Masters CL. Magnetic Resonance Imaging of Vascular Contributions to Cognitive Impairment and Dementia. Journal of Molecular Neuroscience : Mn. PMID 27437942 DOI: 10.1007/s12031-016-0799-3  1
2016 Gu BJ, Huang X, Ou A, Rembach A, Fowler C, Avula PK, Horton A, Doecke JD, Villemagne VL, Macaulay SL, Maruff P, Fletcher EL, Guymer R, Wiley JS, Masters CL, et al. Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's disease. Acta Neuropathologica. PMID 27411339 DOI: 10.1007/S00401-016-1596-3  1
2016 Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Scientific Reports. 6: 29078. PMID 27381087 DOI: 10.1038/Srep29078  1
2016 Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust WJ, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, ... ... Masters CL, et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain : a Journal of Neurology. PMID 27357349 DOI: 10.1093/Brain/Aww159  1
2016 Frost S, Guymer R, Aung KZ, Macaulay SL, Sohrabi HR, Bourgeat P, Salvado O, Rowe CC, Ames D, Masters CL, Martins RN, Kanagasingam Y, Group AT. Alzheimer`s disease and the early signs of age-related macular degeneration. Current Alzheimer Research. PMID 27335042 DOI: 10.2174/1567205013666160603003800  1
2016 Albrecht MA, Masters CL, Ames D, Foster JK. Impact of Mild Head Injury on Neuropsychological Performance in Healthy Older Adults: Longitudinal Assessment in the AIBL Cohort. Frontiers in Aging Neuroscience. 8: 105. PMID 27242516 DOI: 10.3389/Fnagi.2016.00105  1
2016 Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN, et al. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 18-26. PMID 27239546 DOI: 10.1016/J.Dadm.2015.12.001  1
2016 Lim YY, Snyder PJ, Pietrzak RH, Ukiqi A, Villemagne VL, Ames D, Salvado O, Bourgeat P, Martins RN, Masters CL, Rowe CC, Maruff P. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score. Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 19-26. PMID 27239532 DOI: 10.1016/j.dadm.2015.11.003  1
2016 Hare DJ, Raven EP, Roberts BR, Bogeski M, Portbury SD, McLean CA, Masters CL, Connor JR, Bush AI, Crouch PJ, Doble PA. Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and grey matter iron distribution in Alzheimer's disease frontal cortex. Neuroimage. PMID 27233149 DOI: 10.1016/J.Neuroimage.2016.05.057  1
2016 Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, Rainey-Smith S, Martins RN, Salvado O, Villemagne VL, Rowe CC, Masters CL, Maruff P. Amyloid burden and incident depressive symptoms in cognitively normal older adults. International Journal of Geriatric Psychiatry. PMID 27114112 DOI: 10.1002/gps.4489  1
2016 Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN, et al. The Relationship between Sleep Quality and Brain Amyloid Burden. Sleep. PMID 27091528  1
2016 Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Porter T, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Martins RN, Salvado O, Bourgeat P, Rowe CC, Masters CL, Maruff P. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease. Neurology. PMID 27029632 DOI: 10.1212/Wnl.0000000000002604  1
2016 Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Masters CL, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1016/J.Jalz.2015.07.133  1
2016 Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, ... ... Masters CL, et al. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. Plos One. 11: e0152082. PMID 27010959 DOI: 10.1371/Journal.Pone.0152082  1
2016 François M, Fenech MF, Thomas P, Hor M, Rembach A, Martins RN, Rainey-Smith SR, Masters CL, Ames D, Rowe CC, Lance Macaulay S, Hill AF, Leifert WR, The Australian Imaging Biomarkers And Lifestyle Study Research Group. High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease. Current Alzheimer Research. PMID 26975368 DOI: 10.2174/1567205013666160315112151  1
2016 Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, Rainey-Smith S, Lautenschlager N, Rowe CC, Savage G, Villemagne VL, Ellis KA. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26852195 DOI: 10.1016/j.jalz.2015.12.013  1
2016 Chatterjee P, Lim WL, Shui G, Gupta VB, James I, Fagan AM, Xiong C, Sohrabi HR, Taddei K, Brown BM, Benzinger T, Masters C, Snowden SG, Wenk MR, Bateman RJ, et al. Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 26836186 DOI: 10.3233/Jad-150948  1
2016 Ryan TM, Griffin MD, McGillivray DJ, Knott RB, Wood K, Masters CL, Kirby N, Curtain CC. Apolipoprotein C-II Adopts Distinct Structures in Complex with Micellar and Submicellar Forms of the Amyloid-Inhibiting Lipid-Mimetic Dodecylphosphocholine. Biophysical Journal. 110: 85-94. PMID 26745412 DOI: 10.1016/j.bpj.2015.11.007  1
2016 Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN. The relationship between sleep quality and brain amyloid burden Sleep. 39: 1063-1068. DOI: 10.5665/sleep.5756  1
2016 Buckley RF, Rowe CC, Doré V, Laws SM, Bourgeat P, Burnham S, Salvado O, Maruff P, Macaulay SL, Martins RN, Masters CL, Villemagne VL. Mesial Temporal Tau Burden In Older Adults With Subjective Memory Complaints Relates To Poorer Memory Function Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.637  1
2016 Buckles V, Xiong C, Weng H, Bateman R, Chhatwal JP, Ghetti B, Goate A, Graff-Radford NR, Hassenstab J, Mayeux R, Masters CL, McDade E, Moulder KL, Paumier KL, Ringman JM, et al. The Dian-Nacc Uds Comparison Study: Rates Of Cognitive Decline Alzheimers & Dementia. 12: 309. DOI: 10.1016/J.Jalz.2016.06.559  1
2016 Pietrzak RH, Laws SM, Lim YY, Bender SJ, Porter T, Ames D, Fowler C, Masters CL, Milicic L, Rainey-Smith SR, Villemagne VL, Rowe CC, Martins RN, Maruff P. Plasma Cortisol, Amyloid-B, And Cognitive Decline In Preclinical Alzheimer’S Disease Alzheimers & Dementia. 12: 960. DOI: 10.1016/J.Jalz.2016.06.1972  1
2016 Lim YY, Rainey-Smith SR, Laws SM, Gupta V, Porter T, Bourgeat P, Ames D, Fowler C, Salvado O, Villemagne VL, Rowe CC, Masters CL, Martins RN, Maruff P. Effects Of Ab And Bdnf Val66Met On Episodic Memory, Hippocampal Volume And Serum Bdnf In Preclinical Alzheimer’S Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1967  1
2016 Gu BJ, Ou A, Huang X, Rembach A, Fowler C, Doecke JD, Villemagne VL, Maruff P, Macaulay SL, Guymer R, Wiley JS, Masters CL. Altered Peripheral Monocyte Innate Phagocytosis In Alzheimer’S Disease Alzheimers & Dementia. 12: 866. DOI: 10.1016/J.Jalz.2016.06.1781  1
2016 Yates PA, Rowe CC, Ames D, Masters CL, Martins RN, Burnham S, Maruff P, Ellis KA, Villemagne VL. ANTIHYPERTENSIVE TREATMENT AND LONGITUDINAL Aβ MEASURES: RESULTS FROM THE AIBL STUDY OF AGEING Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1049  1
2016 Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 3: 18-26. DOI: 10.1016/j.dadm.2015.12.001  1
2015 Kerestes R, Phal PM, Steward C, Moffat BA, Salinas S, Cox KL, Ellis KA, Cyarto EV, Ames D, Martins RN, Masters CL, Rowe CC, Sharman MJ, Salvado O, Szoeke C, et al. Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease. Bjpsych Open. 1: 139-148. PMID 27703739 DOI: 10.1192/bjpo.bp.115.001339  1
2015 Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer's disease. Nature Reviews. Disease Primers. 1: 15056. PMID 27188934 DOI: 10.1038/nrdp.2015.56  1
2015 Gunn AP, Wong BX, Johanssen T, Griffith JC, Masters CL, Bush AI, Barnham KJ, Duce JA, Cherny RA. Amyloid-Beta Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization and Calcium-Influx in Neurons. The Journal of Biological Chemistry. PMID 26697885 DOI: 10.1074/Jbc.M115.655183  1
2015 Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, ... ... Masters CL, et al. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. Journal of Alzheimer's Disease : Jad. PMID 26639956 DOI: 10.3233/Jad-150446  1
2015 Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, ... ... Masters CL, et al. Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology. Alzheimer's Research & Therapy. 7: 71. PMID 26581886 DOI: 10.1186/s13195-015-0157-7  1
2015 Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment. Age and Ageing. 44: 1012-9. PMID 26452663 DOI: 10.1093/Ageing/Afv136  1
2015 Thai C, Lim YY, Villemagne VL, Laws SM, Ames D, Ellis KA, Rainey-Smith SR, Martins RN, Masters CL, Rowe CC, Maruff P. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months. Plos One. 10: e0139082. PMID 26430784 DOI: 10.1371/journal.pone.0139082  1
2015 Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study. Journal of Alzheimer's Disease : Jad. 46: 1079-89. PMID 26402634 DOI: 10.3233/JAD-143015  1
2015 Leifert WR, Nguyen T, Rembach A, Martins R, Rainey-Smith S, Masters CL, Ames D, Rowe CC, Macaulay SL, François M, Fenech MF. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk. Journal of Alzheimer's Disease : Jad. 48: 443-52. PMID 26402008 DOI: 10.3233/Jad-150330  1
2015 Li QX, Villemagne VL, Doecke JD, Rembach A, Sarros S, Varghese S, McGlade A, Laughton KM, Pertile KK, Fowler CJ, Rumble RL, Trounson BO, Taddei K, Rainey-Smith SR, Laws SM, ... ... Masters CL, et al. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Alzheimer's Disease : Jad. 48: 175-87. PMID 26401938 DOI: 10.3233/JAD-150247  1
2015 Banik A, Brown RE, Bamburg J, Lahiri DK, Khurana D, Friedland RP, Chen W, Ding Y, Mudher A, Padjen AL, Mukaetova-Ladinska E, Ihara M, Srivastava S, Padma Srivastava MV, Masters CL, et al. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1. Journal of Alzheimer's Disease : Jad. 47: 815-43. PMID 26401762 DOI: 10.3233/Jad-150136  1
2015 Gardener SL, Rainey-Smith SR, Macaulay SL, Taddei K, Rembach A, Maruff P, Ellis KA, Masters CL, Rowe CC, Ames D, Keogh JB, Martins RN. Comparative analysis of the Cancer Council of Victoria and the online Commonwealth Scientific and Industrial Research Organisation FFQ. The British Journal of Nutrition. 114: 1683-93. PMID 26382226 DOI: 10.1017/S0007114515003335  1
2015 Li X, Lei P, Tuo Q, Ayton S, Li QX, Moon S, Volitakis I, Liu R, Masters CL, Finkelstein DI, Bush AI. Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 862-73. PMID 26260389 DOI: 10.1007/S13311-015-0378-2  1
2015 Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, ... ... Masters CL, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903  1
2015 Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease. Alzheimer's Research & Therapy. 7: 50. PMID 26203303 DOI: 10.1186/S13195-015-0135-0  1
2015 Merkel B, Steward C, Vivash L, Malpas CB, Phal P, Moffat BA, Cox KL, Ellis KA, Ames DJ, Cyarto EV, Lai MM, Sharman MJ, Szoeke C, Masters CL, Lautenschlager NT, et al. Semi-automated hippocampal segmentation in people with cognitive impairment using an age appropriate template for registration. Journal of Magnetic Resonance Imaging : Jmri. PMID 26140584 DOI: 10.1002/Jmri.24966  1
2015 Albrecht MA, Szoeke C, Maruff P, Savage G, Lautenschlager NT, Ellis KA, Taddei K, Martins R, Masters CL, Ames D, Foster JK. Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status. Neuropsychologia. 75: 411-419. PMID 26102189 DOI: 10.1016/J.Neuropsychologia.2015.06.008  1
2015 Gupta VB, Wilson AC, Burnham S, Hone E, Pedrini S, Laws SM, Lim WL, Rembach A, Rainey-Smith S, Ames D, Cobiac L, Macaulay SL, Masters CL, Rowe CC, Bush AI, et al. Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. Alzheimer's Research & Therapy. 7: 16. PMID 25859282 DOI: 10.1186/S13195-015-0105-6  1
2015 Ellett LJ, Coleman BM, Shambrook MC, Johanssen VA, Collins SJ, Masters CL, Hill AF, Lawson VA. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates. Glycobiology. 25: 745-55. PMID 25701659 DOI: 10.1093/glycob/cwv014  1
2015 Ryan TM, Roberts BR, McColl G, Hare DJ, Doble PA, Li QX, Lind M, Roberts AM, Mertens HD, Kirby N, Pham CL, Hinds MG, Adlard PA, Barnham KJ, Curtain CC, ... Masters CL, et al. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 2871-84. PMID 25698727 DOI: 10.1523/Jneurosci.2912-14.2015  1
2015 Ringman JM, Liang LJ, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, et al. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network. Brain : a Journal of Neurology. 138: 1036-45. PMID 25688083 DOI: 10.1093/Brain/Awv004  1
2015 Ryan TM, Kirby N, Mertens HD, Roberts B, Barnham KJ, Cappai R, Pham Cle L, Masters CL, Curtain CC. Small angle X-ray scattering analysis of Cu(2+)-induced oligomers of the Alzheimer's amyloid β peptide. Metallomics : Integrated Biometal Science. 7: 536-43. PMID 25687761 DOI: 10.1039/c4mt00323c  1
2015 Buckley RF, Ellis KA, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Villemagne VL, Macaulay SL, Szoeke C, Martins RN, Masters CL, Savage G, Rainey-Smith SR, Rembach A, Saling MM, et al. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. Neuropsychology. 29: 571-81. PMID 25664464 DOI: 10.1037/Neu0000156  1
2015 Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. Jama Psychiatry. 72: 284-91. PMID 25629787 DOI: 10.1001/jamapsychiatry.2014.2476  1
2015 Monserrate AE, Ryman DC, Ma S, Xiong C, Noble JM, Ringman JM, Morris JC, Danek A, Müller-Sarnowski F, Clifford DB, McDade EM, Brooks WS, Darby DG, Masters CL, Weston PS, et al. Factors associated with the onset and persistence of post-lumbar puncture headache. Jama Neurology. 72: 325-32. PMID 25622095 DOI: 10.1001/Jamaneurol.2014.3974  1
2015 Rembach A, Stingo FC, Peterson C, Vannucci M, Do KA, Wilson WJ, Macaulay SL, Ryan TM, Martins RN, Ames D, Masters CL, Doecke JD. Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 917-25. PMID 25613103 DOI: 10.3233/Jad-141497  1
2015 Hare DJ, Doecke JD, Faux NG, Rembach A, Volitakis I, Fowler CJ, Grimm R, Doble PA, Cherny RA, Masters CL, Bush AI, Roberts BR. Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation. Acs Chemical Neuroscience. 6: 398-402. PMID 25588002 DOI: 10.1021/Cn5003557  1
2015 Pietrzak RH, Lim YY, Ames D, Harrington K, Restrepo C, Martins RN, Rembach A, Laws SM, Masters CL, Villemagne VL, Rowe CC, Maruff P. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Neurobiology of Aging. 36: 1231-8. PMID 25585532 DOI: 10.1016/j.neurobiolaging.2014.12.015  1
2015 Lim YY, Villemagne VL, Pietrzak RH, Ames D, Ellis KA, Harrington K, Snyder PJ, Martins RN, Masters CL, Rowe CC, Maruff P. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease. Neurobiology of Aging. 36: 1239-44. PMID 25559335 DOI: 10.1016/j.neurobiolaging.2014.12.008  1
2015 Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early progress and future directions. The Lancet. Neurology. 14: 114-24. PMID 25496902 DOI: 10.1016/S1474-4422(14)70252-2  1
2015 Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, Harrington K, Salvado O, Martins RN, Snyder PJ, Masters CL, Rowe CC, Villemagne VL, Maruff P. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 30: 49-58. PMID 25467942 DOI: 10.1093/arclin/acu068  1
2015 Murphy M, Wilson YM, Vargas E, Munro KM, Smith B, Huang A, Li QX, Xiao J, Masters CL, Reid CA, Barrett GL. Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer's disease. Neurobiology of Aging. 36: 740-52. PMID 25443284 DOI: 10.1016/j.neurobiolaging.2014.09.014  1
2015 Roberts BR, Hare DJ, McLean CA, Conquest A, Lind M, Li QX, Bush AI, Masters CL, Morganti-Kossmann MC, Frugier T. Traumatic brain injury induces elevation of Co in the human brain. Metallomics : Integrated Biometal Science. 7: 66-70. PMID 25424382 DOI: 10.1039/C4Mt00258J  1
2015 Watt AD, Perez KA, Ang CS, O'Donnell P, Rembach A, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Faux NG, Masters CL, Villemagne VL, Barnham KJ. Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 1131-43. PMID 25408207 DOI: 10.3233/JAD-142286  1
2015 Curtain CC, Kirby NM, Mertens HD, Barnham KJ, Knott RB, Masters CL, Cappai R, Rekas A, Kenche VB, Ryan T. Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study. Molecular Biosystems. 11: 190-6. PMID 25352253 DOI: 10.1039/c4mb00356j  1
2015 Bourgeat P, Villemagne VL, Dore V, Brown B, Macaulay SL, Martins R, Masters CL, Ames D, Ellis K, Rowe CC, Salvado O, Fripp J. Comparison of MR-less PiB SUVR quantification methods. Neurobiology of Aging. 36: S159-66. PMID 25257985 DOI: 10.1016/J.Neurobiolaging.2014.04.033  1
2015 Robb E, Perez K, Hung LW, Masters CL, Barnham KJ, Cherny RA, Bush AI, Adlard PA, Finkelstein DI. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer. Journal of Alzheimer's Disease : Jad. 44: 69-78. PMID 25182735 DOI: 10.3233/Jad-132024  1
2015 Hollands S, Lim YY, Buckley R, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Lautenschlager N, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. Journal of Alzheimer's Disease : Jad. 43: 677-86. PMID 25114076 DOI: 10.3233/JAD-140678  1
2015 Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, et al. Dietary patterns and cognitive decline in an Australian study of ageing. Molecular Psychiatry. 20: 860-6. PMID 25070537 DOI: 10.1038/Mp.2014.79  1
2015 Ong KT, Villemagne VL, Bahar-Fuchs A, Lamb F, Langdon N, Catafau AM, Stephens AW, Seibyl J, Dinkelborg LM, Reininger CB, Putz B, Rohde B, Masters CL, Rowe CC. Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 431-6. PMID 24970906 DOI: 10.1136/jnnp-2014-308094  1
2015 Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study Journal of Alzheimer's Disease. 46: 1079-1089. DOI: 10.3233/JAD-143015  1
2015 Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease Alzheimer's Research and Therapy. 7. DOI: 10.1186/s13195-015-0135-0  1
2015 Grill JD, Bateman R, Buckles V, Oliver A, Morris JC, Klunk W, Masters C, Ringman JM. Attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease Alzheimers & Dementia. 11: 756. DOI: 10.1016/J.Jalz.2015.06.1685  1
2015 Li X, Lei P, Tuo Q, Ayton S, Li QX, Moon S, Volitakis I, Liu R, Masters CL, Finkelstein DI, Bush AI. Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau Neurotherapeutics. DOI: 10.1007/s13311-015-0378-2  1
2014 Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ. Creutzfeldt-Jakob disease surveillance in Australia, update to December 2013. Communicable Diseases Intelligence Quarterly Report. 38: E348-55. PMID 25631598  1
2014 Johnson P, Vandewater L, Wilson W, Maruff P, Savage G, Graham P, Macaulay LS, Ellis KA, Szoeke C, Martins RN, Rowe CC, Masters CL, Ames D, Zhang P. Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease. Bmc Bioinformatics. 15: S11. PMID 25521394 DOI: 10.1186/1471-2105-15-S16-S11  1
2014 Villemagne VL, Masters CL. Alzheimer disease: the landscape of ageing--insights from AD imaging markers. Nature Reviews. Neurology. 10: 678-9. PMID 25366111 DOI: 10.1038/Nrneurol.2014.214  1
2014 Zwan MD, Okamura N, Fodero-Tavoletti MT, Furumoto S, Masters CL, Rowe CC, Villemagne VL. Voyage au bout de la nuit: Aβ and tau imaging in dementias. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 58: 398-412. PMID 25358680  1
2014 Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Molecular Psychiatry. PMID 25349172 DOI: 10.1038/mp.2014.127  1
2014 Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease. Molecular Psychiatry. PMID 25288138 DOI: 10.1038/mp.2014.123  1
2014 Caine JM, Churches Q, Waddington L, Nigro J, Breheney K, Masters CL, Nuttall SD, Streltsov VA. Design of non-aggregating variants of Aβ peptide. Biochemical and Biophysical Research Communications. 453: 449-54. PMID 25281534 DOI: 10.1016/J.Bbrc.2014.09.102  1
2014 Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Current Neurology and Neuroscience Reports. 14: 499. PMID 25217249 DOI: 10.1007/S11910-014-0499-8  1
2014 Brown BM, Bourgeat P, Peiffer JJ, Burnham S, Laws SM, Rainey-Smith SR, Bartrés-Faz D, Villemagne VL, Taddei K, Rembach A, Bush A, Ellis KA, Macaulay SL, Rowe CC, Ames D, ... Masters CL, et al. Influence of BDNF Val66Met on the relationship between physical activity and brain volume. Neurology. 83: 1345-52. PMID 25186863 DOI: 10.1212/Wnl.0000000000000867  1
2014 Adlard PA, Li QX, McLean C, Masters CL, Bush AI, Fodero-Tavoletti M, Villemagne V, Barnham KJ. β-amyloid in biological samples: not all Aβ detection methods are created equal. Frontiers in Aging Neuroscience. 6: 203. PMID 25165449 DOI: 10.3389/Fnagi.2014.00203  1
2014 Masters CL. Shaken, not sonicated? The New England Journal of Medicine. 371: 571-2. PMID 25099583 DOI: 10.1056/NEJMe1407419  1
2014 Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, ... ... Masters CL, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. Jama Neurology. 71: 1111-22. PMID 25069482 DOI: 10.1001/Jamaneurol.2014.1654  1
2014 Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Villemagne VL, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Szoeke C, Masters CL, Rainey-Smith SR, Rembach A, Savage G, et al. Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults. International Psychogeriatrics / Ipa. 26: 1737-46. PMID 24969443 DOI: 10.1017/S1041610214001136  1
2014 Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 83: 253-60. PMID 24928124 DOI: 10.1212/Wnl.0000000000000596  1
2014 Rembach A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD. An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation. Journal of Neuroimmunology. 273: 65-71. PMID 24907904 DOI: 10.1016/J.Jneuroim.2014.05.005  1
2014 Roberts BR, Lim NK, McAllum EJ, Donnelly PS, Hare DJ, Doble PA, Turner BJ, Price KA, Lim SC, Paterson BM, Hickey JL, Rhoads TW, Williams JR, Kanninen KM, Hung LW, ... ... Masters CL, et al. Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8021-31. PMID 24899723 DOI: 10.1523/Jneurosci.4196-13.2014  1
2014 Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters CL, Yanai K, Rowe CC, Villemagne VL. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET. Brain : a Journal of Neurology. 137: 1762-71. PMID 24681664 DOI: 10.1093/brain/awu064  1
2014 Rembach A, Hare DJ, Doecke JD, Burnham SC, Volitakis I, Fowler CJ, Cherny RA, McLean C, Grimm R, Martins R, Ames D, Masters CL, Bush AI, Roberts BR. Decreased serum zinc is an effect of ageing and not Alzheimer's disease. Metallomics : Integrated Biometal Science. 6: 1216-9. PMID 24676028 DOI: 10.1039/C4Mt00060A  1
2014 Yates PA, Desmond PM, Phal PM, Steward C, Szoeke C, Salvado O, Ellis KA, Martins RN, Masters CL, Ames D, Villemagne VL, Rowe CC. Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology. 82: 1266-73. PMID 24623839 DOI: 10.1212/Wnl.0000000000000285  1
2014 Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/Scitranslmed.3007901  1
2014 Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC. Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 743-751.e1. PMID 24589436 DOI: 10.1016/j.jalz.2013.11.005  1
2014 Fodero-Tavoletti MT, Furumoto S, Taylor L, McLean CA, Mulligan RS, Birchall I, Harada R, Masters CL, Yanai K, Kudo Y, Rowe CC, Okamura N, Villemagne VL. Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies. Alzheimer's Research & Therapy. 6: 11. PMID 24572336 DOI: 10.1186/Alzrt240  1
2014 Pietrzak RH, Scott JC, Neumeister A, Lim YY, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study. The British Journal of Psychiatry : the Journal of Mental Science. 204: 400-1. PMID 24526746 DOI: 10.1192/Bjp.Bp.113.134239  1
2014 Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Doré V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 41: 816-26. PMID 24514874 DOI: 10.1007/S00259-013-2681-7  1
2014 Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Szoeke C, Ellis KA. Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing. Journal of Alzheimer's Disease : Jad. 40: 551-61. PMID 24496075 DOI: 10.3233/Jad-131820  1
2014 Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington K, Bourgeat P, Bush AI, Martins RN, Masters CL, Rowe CC, Maruff P. Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study. Plos One. 9: e86498. PMID 24475133 DOI: 10.1371/Journal.Pone.0086498  1
2014 Johanssen VA, Johanssen T, Masters CL, Hill AF, Barnham KJ, Collins SJ. C-terminal peptides modelling constitutive PrPC processing demonstrate ameliorated toxicity predisposition consequent to α-cleavage. The Biochemical Journal. 459: 103-15. PMID 24438129 DOI: 10.1042/Bj20131378  1
2014 Yates PA, Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC. Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Frontiers in Neurology. 4: 205. PMID 24432010 DOI: 10.3389/Fneur.2013.00205  1
2014 Zhou L, Salvado O, Dore V, Bourgeat P, Raniga P, Macaulay SL, Ames D, Masters CL, Ellis KA, Villemagne VL, Rowe CC, Fripp J. MR-less surface-based amyloid assessment based on 11C PiB PET. Plos One. 9: e84777. PMID 24427295 DOI: 10.1371/journal.pone.0084777  1
2014 Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL, Bush AI. An anemia of Alzheimer's disease. Molecular Psychiatry. 19: 1227-34. PMID 24419041 DOI: 10.1038/Mp.2013.178  1
2014 Coleman BM, Harrison CF, Guo B, Masters CL, Barnham KJ, Lawson VA, Hill AF. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality. Journal of Virology. 88: 2690-703. PMID 24352465 DOI: 10.1128/Jvi.02720-13  1
2014 Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. Journal of Alzheimer's Disease : Jad. 40: 95-104. PMID 24334723 DOI: 10.3233/Jad-131802  1
2014 Ellis KA, Szoeke C, Bush AI, Darby D, Graham PL, Lautenschlager NT, Macaulay SL, Martins RN, Maruff P, Masters CL, McBride SJ, Pike KE, Rainey-Smith SR, Rembach A, Robertson J, et al. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). International Psychogeriatrics / Ipa. 26: 543-54. PMID 24252258 DOI: 10.1017/S1041610213001956  1
2014 Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, Boundy K, Ellis KA, Bush AI, Faux NG, Martins RN, Masters CL, Rowe CC, Szoeke C, Watters DA. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. Journal of Alzheimer's Disease : Jad. 39: 661-8. PMID 24246419 DOI: 10.3233/Jad-131265  1
2014 Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain : a Journal of Neurology. 137: 221-31. PMID 24176981 DOI: 10.1093/brain/awt286  1
2014 Pham CL, Kirby N, Wood K, Ryan T, Roberts B, Sokolova A, Barnham KJ, Masters CL, Knott RB, Cappai R, Curtain CC, Rekas A. Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study. Proteins. 82: 10-21. PMID 23733394 DOI: 10.1002/prot.24332  1
2014 Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, ... ... Masters CL, et al. A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Molecular Psychiatry. 19: 519-26. PMID 23628985 DOI: 10.1038/Mp.2013.40  1
2014 Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Roberts BR, Perez KA, Li QX, Laws SM, Taddei K, Rainey-Smith S, Robertson JS, Vandijck M, ... ... Masters CL, et al. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 53-61. PMID 23491263 DOI: 10.1016/J.Jalz.2012.12.006  1
2014 Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, Faux NG, Gupta VB, Li QX, Masters CL, Pike KE, Rowe CC, Szoeke C, Taddei K, Villemagne VL, et al. Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. Molecular Psychiatry. 19: 69-75. PMID 23089633 DOI: 10.1038/Mp.2012.147  1
2014 Drew SC, Masters CL, Barnham KJ. Alzheimer's Aβ peptides with disease-associated N-terminal modifications: Influence of isomerisation, truncation and mutation on Cu 2+ coordination (PLoS ONE (2010) 5, 12 (e15875) DOI: 10.1371/journal.pone.0015875) Plos One. 9. DOI: 10.1371/journal.pone.0102192  1
2014 Hare DJ, George JL, Bray L, Volitakis I, Vais A, Ryan TM, Cherny RA, Bush AI, Masters CL, Adlard PA, Doble PA, Finkelstein DI. Errratum: The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue (Journal of Analytical Atomic Spectrometry (2013) DOI: 10.1039/C3JA50281C) Journal of Analytical Atomic Spectrometry. 29: 1726. DOI: 10.1039/C4JA90043J  1
2014 Hare DJ, Lei P, Ayton S, Roberts BR, Grimm R, George JL, Bishop DP, Beavis AD, Donovan SJ, McColl G, Volitakis I, Masters CL, Adlard PA, Cherny RA, Bush AI, et al. An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta Chemical Science. 5: 2160-2169. DOI: 10.1039/C3Sc53461H  1
2014 Hare DJ, George JL, Bray L, Volitakis I, Vais A, Ryan TM, Cherny RA, Bush AI, Masters CL, Adlard PA, Doble PA, Finkelstein DI. The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue Journal of Analytical Atomic Spectrometry. 29: 565-570. DOI: 10.1039/C3Ja50281C  1
2014 Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA, Martins R, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Twyman R, et al. Comparison Of Three Normative Data Correction Approaches: A Cross-Sectional Evaluation In The Aibl Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.07.064  1
2014 Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA, Martins R, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Twyman R, et al. Novel Statistically-Derived Composite Measures For Assessing The Efficacy Of Disease-Modifying Therapies In Prodromal Ad Trials: An Aipl Study Alzheimers & Dementia. 10: 567. DOI: 10.1016/J.Jalz.2014.05.927  1
2014 Szoeke C, Robertson JS, Lehert P, Rowe CC, Masters CL, Ames D, Dennerstein L, Desmond P. A Simple Test Of Episodic Memory Predicts Conversion To Disease (Mci/Ad) A Decade Later: Data From The Women’S Healthy Ageing Project (Whap) Alzheimers & Dementia. 10: 435. DOI: 10.1016/J.Jalz.2014.05.576  1
2014 Lim YY, Villemagne VL, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Martins RN, Masters CL, Rowe CC, Maruff P. Utility Of The Cognigram Brief Battery In Assessing Cognitive Changes Associated With Ab And Apoe Genotype In Preclinical Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.563  1
2014 Maruff PT, Hollands S, Lim YY, Buckley R, Villemange V, Pietrzak R, Snyder PJ, Ames D, Ellis KA, Harrington K, Martins RN, Masters CL, Rowe CC. Healthy Adults With Amyloid-Related Memory Decline Report No Concomitant Decline In Subjective Reports Of Their Memory Impairment Alzheimers & Dementia. 10: 380. DOI: 10.1016/J.Jalz.2014.05.450  1
2014 McCluskey GE, Yates PA, Rowe CC, Ames D, Masters CL, Dennerstein L, Desmond P, Szoeke C. Reported episodes of confusion in healthy participants have a relationship with cerebral amyloid load: Data from the women's healthy ageing project Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1601  1
2014 Gupta VB, Pedrini S, Hone E, Deocke J, Obryant S, Masters CL, Martins R. Peripheral Biomarkers Differentiate Between Transitional And Non-Transitional Clinical Groups In The Longitudinal Australian Imaging Biomarkers And Lifestyle Study Of Aging Alzheimers & Dementia. 10: 807. DOI: 10.1016/J.Jalz.2014.05.1582  1
2014 Szoeke C, Lehert P, Yates PA, Villemagne VL, Masters CL, Ames D, Dennerstein L, Desmond P, Rowe CC. Participants With A Positive Amyloid Scan In The Women’S Healthy Ageing Project Had Significantly Worse Episodic Memory Than Those With A Negative Scan Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1571  1
2014 Wilson AC, Garin S, Porter TLS, Verdile G, Groth DM, Villemagne VL, Ames D, Bush AI, Ellis KA, Macaulay L, Masters CL, Rainey-Smith SR, Rembach A, Rowe C, Taddei K, et al. Genetic Analysis Of The Steroidogenesis Pathway: Associations With Alzheimer'S Disease Risk And Related Phenotypes Alzheimers & Dementia. 10: 667. DOI: 10.1016/J.Jalz.2014.05.1195  1
2014 Laws SM, Porter T, Creegan R, Lim WLF, Verdile G, Groth DM, Villemagne V, Wilson AC, Ames D, Bush AI, Ellis KA, Macaulay L, Masters CL, Rainey-Smith SL, Rembach A, et al. Genetic Variation Within Genes Of The Sphingolipid Metabolism Pathway And Their Association With Alzheimer'S Disease Risk And Related Phenotypes Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1110  1
2014 Ong K, Villemagne VL, Bahar-Fuchs A, Lamb F, Langdon N, Catafau A, Stephens A, Seibyl J, Dinkelborg L, Reininger C, Putz B, Rohde B, Masters CL, Rowe CC. DETECTION OF PRODROMAL ALZHEIMER'S DISEASE WITH 18F-FLORBETABEN Aβ IMAGING: A PROSPECTIVE OUTCOME STUDY Alzheimers & Dementia. 10: 42. DOI: 10.1016/J.Jalz.2014.05.080  1
2014 Yates P, Villemagne VL, Bourgeat P, Ellis KA, Martins R, Szoeke C, Desmond P, Masters CL, Ames D, Rowe CC. Brain Beta-Amyloid, Vascular Factors, And Cognition: 54-Month Followup Results From The Aipl Study Alzheimers & Dementia. 10: 17. DOI: 10.1016/J.Jalz.2014.05.026  1
2014 Yates P, Villemagne VL, Robertson J, Dennerstein L, Li C, Desmond P, Masters CL, Szoeke C, Rowe CC. Evidence Of Amyloid On Florbetaben-Pet Is Associated With Reduced Episodic Memory 10 Years Prior: Results From The Women’S Healthy Ageing Project Alzheimers & Dementia. 10: 16. DOI: 10.1016/J.Jalz.2014.05.024  1
2014 Bourgeat P, Doré V, Zhou L, Fripp J, Martins R, Macaulay L, Masters CL, Ames D, Brown B, Rowe CC, Salvado O, Villemagne VL. Automated Reporting Of Amyloid Pet Quantification On Brain Surface Through A Web Interface Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.424  1
2014 Chatterjee P, Lim WLF, Gupta VB, Sohrabi HR, Taddei K, Brown B, Masters CL, Morris JC, Martins R. Altered Plasma Phospholipid Composition In Autosomal Dominant Alzheimer'S Disease: A Dian Study Alzheimers & Dementia. 10: 260. DOI: 10.1016/J.Jalz.2014.04.412  1
2014 Villemagne VL, Burnham S, Brown B, Bourgeat P, Ellis KA, Yates P, Veljanovski R, Martins R, Macaulay L, Salvado O, Ames D, Masters CL, Rowe CC. PRECLINICAL EFFECTS OF Aβ DEPOSITION ON EPISODIC MEMORY AND DISEASE PROGRESSION Alzheimers & Dementia. 10: 229. DOI: 10.1016/J.Jalz.2014.04.326  1
2014 Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P. AMYLOID β-RELATED COGNITIVE DECLINE IN PRECLINICAL ALZHEIMER'S DISEASE IS MODERATED BY APOE AND BDNF POLYMORPHISMS Alzheimers & Dementia. 10: 221. DOI: 10.1016/J.Jalz.2014.04.305  1
2014 Burnham SC, Ames D, Baker D, Bush AI, Cobiac L, Doecke J, Ellis KA, Faux NG, Head R, Kiiveri H, Laws SM, Martins R, Maruff P, Savage G, Wilson B, ... ... Masters CL, et al. Predicting Alzheimer'S Disease From A Blood-Based Biomarker Profile: Results From Aipl At 54 Months Alzheimers & Dementia. 10: 196. DOI: 10.1016/J.Jalz.2014.04.233  1
2014 Rowe CC, Dore V, Bourgeat P, Buckley R, Veljanovski R, Salvado O, Ong K, Williams R, Rembach A, Macaulay L, Ames D, Masters CL, Villemagne VL. Higher Ab Burden In Healthy Apoe-E4 Carriers Is Associated With Subjective Memory Complaints: Results From The Flutemetamol And Pib Aipl Cohorts Alzheimers & Dementia. 10: 42. DOI: 10.1016/J.Jalz.2014.04.212  1
2014 Rainey-Smith SR, Brown B, Gardener S, Peiffer J, Bourgeat P, Laws SM, Barnes M, Taddei K, Sohrabi HR, Weinborn M, Rembach A, Burnham S, Villemagne VL, Ellis KA, Macaulay L, ... Masters CL, et al. Apoe Genotype-Dependent Effects Of Diet And Physical Activity On Cognition And Alzheimer'S-Related Pathology: Data From The Aipl Study Of Ageing Alzheimers & Dementia. 10: 166. DOI: 10.1016/J.Jalz.2014.04.165  1
2014 Harrington K, Gould E, Lim YY, Ellis KA, Ames D, Martins R, Savage G, Szoeke C, Rowe CC, Villemagne VL, Masters CL, Maruff P. The Association Between Amyloid Burden And Sub-Clinical Depression In Healthy Older Adults Alzheimers & Dementia. 10: 139. DOI: 10.1016/J.Jalz.2014.04.086  1
2014 Villemagne VL, Fodero-Tavoletti M, Yates P, Masters CL, Rowe CC. Aâ imaging in aging, alzheimer’s disease and other neurodegenerative conditions Pet and Spect in Neurology. 213-254. DOI: 10.1007/978-3-642-54307-4_10  1
2013 Maruff P, Lim YY, Darby D, Ellis KA, Pietrzak RH, Snyder PJ, Bush AI, Szoeke C, Schembri A, Ames D, Masters CL. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease. Bmc Psychology. 1: 30. PMID 25566378 DOI: 10.1186/2050-7283-1-30  1
2013 Rowe CC, Bourgeat P, Ellis KA, Brown B, Lim YY, Mulligan R, Jones G, Maruff P, Woodward M, Price R, Robins P, Tochon-Danguy H, O'Keefe G, Pike KE, Yates P, ... ... Masters CL, et al. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Annals of Neurology. 74: 905-13. PMID 24448836 DOI: 10.1002/Ana.24040  1
2013 Szoeke CE, Robertson JS, Rowe CC, Yates P, Campbell K, Masters CL, Ames D, Dennerstein L, Desmond P. The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementia. International Review of Psychiatry (Abingdon, England). 25: 726-37. PMID 24423225 DOI: 10.3109/09540261.2013.873394  1
2013 Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C, Bush AI, Masters CL, Roberts BR. Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction. International Journal of Alzheimer's Disease. 2013: 623241. PMID 24228186 DOI: 10.1155/2013/623241  1
2013 Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, ... ... Masters CL, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/Pnas.1317918110  1
2013 Klug GM, Boyd A, Zhao T, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ. Surveillance for Creutzfeldt-Jakob disease in Australia: update to December 2012. Communicable Diseases Intelligence Quarterly Report. 37: E115-20. PMID 24168084  1
2013 Hare DJ, Grubman A, Ryan TM, Lothian A, Liddell JR, Grimm R, Matsuda T, Doble PA, Cherny RA, Bush AI, White AR, Masters CL, Roberts BR. Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry. Metallomics : Integrated Biometal Science. 5: 1656-62. PMID 24132241 DOI: 10.1039/C3Mt00227F  1
2013 Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN. Pupil response biomarkers for early detection and monitoring of Alzheimer's disease. Current Alzheimer Research. 10: 931-9. PMID 24117119 DOI: 10.2174/15672050113106660163  1
2013 Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, et al. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology. 81: 1425-33. PMID 24049139 DOI: 10.1212/Wnl.0B013E3182A841C6  1
2013 Klug GM, Wand H, Simpson M, Boyd A, Law M, Masters CL, MatÄ›j R, Howley R, Farrell M, Breithaupt M, Zerr I, van Duijn C, Ibrahim-Verbaas C, Mackenzie J, Will RG, et al. Intensity of human prion disease surveillance predicts observed disease incidence. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1372-7. PMID 23965290 DOI: 10.1136/Jnnp-2012-304820  1
2013 Frost SM, Kanagasingam Y, Sohrabi HR, Taddei K, Bateman R, Morris J, Benzinger T, Goate A, Masters CL, Martins RN. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Current Alzheimer Research. 10: 790-6. PMID 23919771 DOI: 10.2174/15672050113109990154  1
2013 Rembach A, Ryan TM, Roberts BR, Doecke JD, Wilson WJ, Watt AD, Barnham KJ, Masters CL. Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. Biomarkers in Medicine. 7: 641-62. PMID 23905901 DOI: 10.2217/bmm.13.59  1
2013 Lothian A, Hare DJ, Grimm R, Ryan TM, Masters CL, Roberts BR. Metalloproteomics: principles, challenges and applications to neurodegeneration. Frontiers in Aging Neuroscience. 5: 35. PMID 23882215 DOI: 10.3389/fnagi.2013.00035  1
2013 Harrington KD, Lim YY, Ellis KA, Copolov C, Darby D, Weinborn M, Ames D, Martins RN, Savage G, Szoeke C, Rowe C, Villemagne VL, Masters CL, Maruff P. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI. International Psychogeriatrics / Ipa. 25: 1667-77. PMID 23866942 DOI: 10.1017/S1041610213001087  1
2013 Simpson M, Johanssen V, Boyd A, Klug G, Masters CL, Li QX, Pamphlett R, McLean C, Lewis V, Collins SJ. Unusual clinical and molecular-pathological profile of gerstmann-Sträussler-Scheinker disease associated with a novel PRNP mutation (V176G). Jama Neurology. 70: 1180-5. PMID 23857164 DOI: 10.1001/Jamaneurol.2013.165  1
2013 Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington KD, Bourgeat P, Salvado O, Darby D, Snyder PJ, Bush AI, Martins RN, Masters CL, Rowe CC, et al. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 34: 2457-64. PMID 23769397 DOI: 10.1016/J.Neurobiolaging.2013.05.006  1
2013 Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Brain : a Journal of Neurology. 136: 2201-16. PMID 23737466 DOI: 10.1093/Brain/Awt127  1
2013 Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. Jama Neurology. 70: 903-11. PMID 23712469 DOI: 10.1001/Jamaneurol.2013.1062  1
2013 Buckley R, Saling MM, Ames D, Rowe CC, Lautenschlager NT, Macaulay SL, Martins RN, Masters CL, O'Meara T, Savage G, Szoeke C, Villemagne VL, Ellis KA. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age. International Psychogeriatrics / Ipa. 25: 1307-15. PMID 23693133 DOI: 10.1017/S1041610213000665  1
2013 Lim YY, Ellis KA, Harrington K, Kamer A, Pietrzak RH, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Ames D, Maruff P. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease. Neuropsychology. 27: 322-32. PMID 23688214 DOI: 10.1037/A0032321  1
2013 Ryan TM, Caine J, Mertens HD, Kirby N, Nigro J, Breheney K, Waddington LJ, Streltsov VA, Curtain C, Masters CL, Roberts BR. Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization. Peerj. 1: e73. PMID 23678397 DOI: 10.7717/peerj.73  1
2013 Nisbet RM, Nuttall SD, Robert R, Caine JM, Dolezal O, Hattarki M, Pearce LA, Davydova N, Masters CL, Varghese JN, Streltsov VA. Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptide. Proteins. 81: 1748-58. PMID 23609990 DOI: 10.1002/Prot.24312  1
2013 Rowe CC, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, Cselényi Z, Masters CL, Villemagne VL. Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 880-6. PMID 23575995 DOI: 10.2967/Jnumed.112.114785  1
2013 Lim YY, Jaeger J, Harrington K, Ashwood T, Ellis KA, Stöffler A, Szoeke C, Lachovitzki R, Martins RN, Villemagne VL, Bush A, Masters CL, Rowe CC, Ames D, Darby D, et al. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 320-30. PMID 23552802 DOI: 10.1093/Arclin/Act021  1
2013 Kenche VB, Zawisza I, Masters CL, Bal W, Barnham KJ, Drew SC. Mixed ligand Cu2+ complexes of a model therapeutic with Alzheimer's amyloid-β peptide and monoamine neurotransmitters. Inorganic Chemistry. 52: 4303-18. PMID 23537393 DOI: 10.1021/Ic302289R  1
2013 Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. The Lancet. Neurology. 12: 357-67. PMID 23477989 DOI: 10.1016/S1474-4422(13)70044-9  1
2013 Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Translational Psychiatry. 3: e233. PMID 23443359 DOI: 10.1038/Tp.2012.150  1
2013 Kenche VB, Hung LW, Perez K, Volitakes I, Ciccotosto G, Kwok J, Critch N, Sherratt N, Cortes M, Lal V, Masters CL, Murakami K, Cappai R, Adlard PA, Barnham KJ. Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease. Angewandte Chemie (International Ed. in English). 52: 3374-8. PMID 23401085 DOI: 10.1002/anie.201209885  1
2013 Watt AD, Perez KA, Rembach A, Sherrat NA, Hung LW, Johanssen T, McLean CA, Kok WM, Hutton CA, Fodero-Tavoletti M, Masters CL, Villemagne VL, Barnham KJ. Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples. Acta Neuropathologica. 125: 549-64. PMID 23354835 DOI: 10.1007/S00401-013-1083-Z  1
2013 Ong K, Villemagne VL, Bahar-Fuchs A, Lamb F, Chételat G, Raniga P, Mulligan RS, Salvado O, Putz B, Roth K, Masters CL, Reininger CB, Rowe CC. (18)F-florbetaben Aβ imaging in mild cognitive impairment. Alzheimer's Research & Therapy. 5: 4. PMID 23324163 DOI: 10.1186/Alzrt158  1
2013 Ellis KA, Lim YY, Harrington K, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 34: 861-71. PMID 23302660 DOI: 10.3233/Jad-122170  1
2013 Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ. Research and standardization in Alzheimer's trials: reaching international consensus. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 160-8. PMID 23266004 DOI: 10.1016/J.Jalz.2012.10.006  1
2013 Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, ... ... Masters CL, et al. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 34: 171-82. PMID 23168449 DOI: 10.3233/Jad-121474  1
2013 Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease? Journal of Alzheimer's Disease : Jad. 33: 1167-76. PMID 23160011 DOI: 10.3233/Jad-121771  1
2013 Lim YY, Ellis KA, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Aβ amyloid, cognition, and APOE genotype in healthy older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 538-45. PMID 23159043 DOI: 10.1016/J.Jalz.2012.07.004  1
2013 Lim YY, Pietrzak RH, Ellis KA, Jaeger J, Harrington K, Ashwood T, Szoeke C, Martins RN, Bush AI, Masters CL, Rowe CC, Villemagne VL, Ames D, Darby D, Maruff P. Rapid decline in episodic memory in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 33: 675-9. PMID 23001710 DOI: 10.3233/Jad-2012-121516  1
2013 Brown BM, Peiffer JJ, Taddei K, Lui JK, Laws SM, Gupta VB, Taddei T, Ward VK, Rodrigues MA, Burnham S, Rainey-Smith SR, Villemagne VL, Bush A, Ellis KA, Masters CL, et al. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Molecular Psychiatry. 18: 875-81. PMID 22889922 DOI: 10.1038/Mp.2012.107  1
2013 Copolov C, Harrington K, Dow B, Joosten M, Rainey-Smith S, Rodrigues M, Rembach A, Macaulay L, Rowe C, Martins R, Masters C, Ames D, Ellis K. The effect of rapid cognitive decline in MCI and Alzheimer's disease on level of dependence, resource utilization, carer satisfaction, burden and attitudes to aging Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.996  1
2013 Johnson P, Graham P, Wilson B, Macaulay L, Maruff P, Savage G, Ellis K, Martins R, Rowe C, Masters C, Ames D, Zhang P. Genetic algorithm with logistic regression for Alzheimer's disease diagnosis and prognosis Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.913  1
2013 Restrepo C, Saling M, Ames D, Bush A, Faux N, Martins R, Maruff P, Masters C, Rowe C, Szoeke C, Villemagne V, Yates P, Ellis K. The effect of vascular risk factors on the rate of cognitive change in older adults: Data from the Australian Imaging Biomarkers and Lifestyle (AIBL) flagship study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.911  1
2013 Lim YY, Villemagne V, Laws S, Ames D, Pietrzak R, Ellis K, Harrington K, Bourgeat P, Salvado O, Darby D, Snyder P, Bush A, Martins R, Masters C, Rowe C, et al. Modulation of beta-amyloid-related cognitive decline by brain-derived neurotrophic factor Val66Met polymorphism in preclinical Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.893  1
2013 Lim YY, Ellis K, Harrington K, Kamer A, Pietrzak R, Bush A, Darby D, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Ames D, Maruff P. Cognitive consequences of high beta-amyloid levels in people with mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer's disease Alzheimers & Dementia. 9: 446. DOI: 10.1016/J.Jalz.2013.05.891  1
2013 Yates P, Szoeke C, Rowe C, Villemagne V, Steward C, Masters C, Ames D, Ellis K, Langdon N, Dennerstein L, Philippe L, Desmond P. Ten-year MRI changes and FBB-PET: Results from the Women's Healthy Aging Project (WHAP) Alzheimers & Dementia. 9: 401. DOI: 10.1016/J.Jalz.2013.05.796  1
2013 Ryan T, Roberts B, McColl G, Metens H, Kirby N, Howlett G, Curtain C, Barnham K, Masters C. The antioligomer effects of the metal-protein attenuating compound clioquinol Alzheimers & Dementia. 9: 363. DOI: 10.1016/J.Jalz.2013.05.695  1
2013 Okamura N, Furumoto S, Harada R, Fodero-Tavoletti M, Mulligan RS, Masters C, Yanai K, Kudo Y, Rowe C, Villemagne V. In vivo detection of tau protein deposits in Alzheimer's disease using 18F-labeled 2-phenylquinoline derivatives Alzheimers & Dementia. 9: 268. DOI: 10.1016/J.Jalz.2013.05.533  1
2013 Doré V, Bourgeat P, Zhou L, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Brown B, Rowe C, Salvado O, Villemagne V. Cortical surface projection of PET images from 11C- and 18F-labeled radiotracers without magnetic resonance imaging Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.523  1
2013 Fodero-Tavoletti M, Okamura N, Taylor L, Furumoto S, McLean C, Mulligan RS, Birchall I, Harada R, Masters C, Yanai K, Rowe C, Kudo Y, Villemagne V. THK523 selectively binds to neurofibrillary tangles and neuropils in people with Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.519  1
2013 Zhang P, Graham P, Savage G, Jones A, Macaulay L, Masters C, Martins R, Gupta VB, Bush A, Maruff P, Ellis K, Szoeke C, Rowe C, Ames D, Wilson B. Change in cognition over 36 months in relation to blood biomarkers Alzheimers & Dementia. 9: 204. DOI: 10.1016/J.Jalz.2013.05.372  1
2013 Rembach A, Wilson B, Ellis K, Ames D, Rowe C, Villemagne V, Bush A, Martins R, Masters C, Doecke J. Neutrophil-lymphocyte ratio in Alzheimer's disease: Data from the Australian Imaging Biomarker and Lifestyle study of ageing Alzheimers & Dementia. 9: 203. DOI: 10.1016/J.Jalz.2013.05.368  1
2013 Villemagne V, Furumoto S, Fodero-Tavoletti M, Mulligan RS, Harada R, Yates P, Pejoska S, Yanai K, Masters C, Kudo Y, Rowe C, Okamura N. In vivo pattern of tau and beta-amyloid deposition in the brain might distinguish healthy individuals from those with preclinical Alzheimer's disease Alzheimers & Dementia. 9: 94. DOI: 10.1016/J.Jalz.2013.05.155  1
2013 Maruff P, Lim YY, Ames D, Ellis K, Pietrzak R, Savage G, Harrington K, Bush A, Szoeke C, Martins R, Villemagne V, Rowe C, Darby D, Masters C. Clinical utility of the cogstate brief battery in Alzheimer's disease–related memory impairment Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1296  1
2013 Cash D, Ridgway G, Modat M, Ryan N, Kinnunen K, Cardoso J, Benzinger T, Jack CR, Raichle M, Marcus D, Ringman J, Thompson P, Ghetti B, Salloway S, Sperling R, ... ... Masters C, et al. Dissociating volume and intensity differences in familial Alzheimer's disease Alzheimers & Dementia. 9: 603. DOI: 10.1016/J.Jalz.2013.05.075  1
2013 Doré V, Bourgeat P, Zhou L, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Brown B, Rowe C, Salvado O, Villemagne V. MR-less cortical surface-projection of PET images from 11C- and 18F-labeled radiotracers Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.017  1
2013 Rowe C, Ames D, Ellis K, Bourgeat P, Brown B, Salvado O, Szoeke C, Woodward M, Macaulay L, Maruff P, Martins R, Masters C, Villemagne V. Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) Alzheimers & Dementia. 9: 12. DOI: 10.1016/J.Jalz.2013.05.005  1
2013 Bourgeat P, Villemagne V, Dore V, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Rowe C, Salvado O. Automatic 11C PiB SUVR quantification Alzheimers & Dementia. 9: 597. DOI: 10.1016/J.Jalz.2013.05.004  1
2013 Rembach A, Wilson B, Villemagne V, Ellis K, Ames D, Rowe C, Bush A, Martins R, Masters C, Doecke J. Plasma beta-amyloid levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.341  1
2013 Yates P, Rowe C, Villemagne V, Desmond P, Masters C, Ames D, Dennerstein L, Philippe L, Ellis K, Szoeke C. Midlife vascular risk and late-life amyloid burden: Data from the Women's Healthy Ageing Project (WHAP) Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.300  1
2013 Villemagne V, Furumoto S, Fodero-Tavoletti M, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters C, Yanai K, Rowe C, Okamura N. In vivo pattern of tau and beta-amyloid deposition in the brain might distinguish healthy controls from preclinical Alzheimer's disease Alzheimers & Dementia. 9: 534. DOI: 10.1016/J.Jalz.2013.04.283  1
2013 Villemagne V, Burnham S, Bourgeat P, Brown B, Ellis K, Salvado O, Szoeke C, Macaulay L, Martins R, Maruff P, Ames D, Rowe C, Masters C. The natural history of the dynamics of beta-amyloid deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.253  1
2013 Yates P, Villemagne V, Desmond P, Phal P, Steward C, Salvado O, Martins R, Masters C, Ames D, Ellis K, Szoeke C, Rowe C. Microbleeds and clinical trajectories: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Alzheimers & Dementia. 9: 131. DOI: 10.1016/J.Jalz.2013.04.066  1
2013 Gupta VB, Rowe C, Szoeke C, Ames D, Cobiac L, Bush A, Ellis K, Macaulay L, Masters C, Martins R. Establishing apolipoprotein J as a potential candidate for Alzheimer's disease biomarker panel: Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of aging Alzheimers & Dementia. 9: 128. DOI: 10.1016/J.Jalz.2013.04.057  1
2013 Kinnunen K, Ryan N, Cash D, Leite AB, Finnegan S, Cardoso M, Leung K, Modat M, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Ringman J, Ghetti B, ... ... Masters C, et al. Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.017  1
2013 Ryan TM, Roberts BR, Streltsov VA, Nuttall SD, Masters CL. The Role of Aβ in Alzheimer's Disease Amyloid Fibrils and Prefibrillar Aggregates: Molecular and Biological Properties. 263-293. DOI: 10.1002/9783527654185.ch13  1
2012 Klug GM, Boyd A, McGlade A, Stehmann C, Simpson M, Masters CL, Collins SJ. Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2011. Communicable Diseases Intelligence Quarterly Report. 36: E174-9. PMID 23186216  1
2012 McColl G, Roberts BR, Pukala TL, Kenche VB, Roberts CM, Link CD, Ryan TM, Masters CL, Barnham KJ, Bush AI, Cherny RA. Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Molecular Neurodegeneration. 7: 57. PMID 23171715 DOI: 10.1186/1750-1326-7-57  1
2012 Brown BM, Peiffer JJ, Sohrabi HR, Mondal A, Gupta VB, Rainey-Smith SR, Taddei K, Burnham S, Ellis KA, Szoeke C, Masters CL, Ames D, Rowe CC, Martins RN. Intense physical activity is associated with cognitive performance in the elderly. Translational Psychiatry. 2: e191. PMID 23168991 DOI: 10.1038/Tp.2012.118  1
2012 Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical Investigation. 2: 975-984. PMID 23139856 DOI: 10.4155/Cli.12.93  1
2012 Lim YY, Ellis KA, Pietrzak RH, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology. 79: 1645-52. PMID 23071163 DOI: 10.1212/Wnl.0B013E31826E9Ae6  1
2012 Cyarto EV, Lautenschlager NT, Desmond PM, Ames D, Szoeke C, Salvado O, Sharman MJ, Ellis KA, Phal PM, Masters CL, Rowe CC, Martins RN, Cox KL. Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial. Bmc Psychiatry. 12: 167. PMID 23050829 DOI: 10.1186/1471-244X-12-167  1
2012 Gardener S, Gu Y, Rainey-Smith SR, Keogh JB, Clifton PM, Mathieson SL, Taddei K, Mondal A, Ward VK, Scarmeas N, Barnes M, Ellis KA, Head R, Masters CL, Ames D, et al. Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Translational Psychiatry. 2: e164. PMID 23032941 DOI: 10.1038/Tp.2012.91  1
2012 Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, ... ... Masters CL, et al. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 445-52. PMID 22959699 DOI: 10.1016/J.Jalz.2012.08.001  1
2012 Klemm HM, Welton JM, Masters CL, Klug GM, Boyd A, Hill AF, Collins SJ, Lawson VA. The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. The Journal of Biological Chemistry. 287: 36465-72. PMID 22930754 DOI: 10.1074/Jbc.M112.368803  1
2012 Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, ... ... Masters CL, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Archives of Neurology. 69: 1318-25. PMID 22801742 DOI: 10.1001/Archneurol.2012.1282  1
2012 Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, ... ... Masters CL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine. 367: 795-804. PMID 22784036 DOI: 10.1056/Nejmoa1202753  1
2012 Anand A, Banik A, Thakur K, Masters CL. The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation. Current Alzheimer Research. 9: 1010-29. PMID 22698073 DOI: 10.2174/156720512803569055  1
2012 Masters CL, Selkoe DJ. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine. 2: a006262. PMID 22675658 DOI: 10.1101/Cshperspect.A006262  1
2012 Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain : a Journal of Neurology. 135: 2126-39. PMID 22628162 DOI: 10.1093/Brain/Aws125  1
2012 Lewis V, Haigh CL, Masters CL, Hill AF, Lawson VA, Collins SJ. Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity. Molecular Neurodegeneration. 7: 18. PMID 22534096 DOI: 10.1186/1750-1326-7-18  1
2012 Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. Journal of Neurochemistry. 122: 208-20. PMID 22519988 DOI: 10.1111/J.1471-4159.2012.07761.X  1
2012 Fodero-Tavoletti MT, Brockschnieder D, Villemagne VL, Martin L, Connor AR, Thiele A, Berndt M, McLean CA, Krause S, Rowe CC, Masters CL, Dinkelborg L, Dyrks T, Cappai R. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer. Nuclear Medicine and Biology. 39: 1042-8. PMID 22503458 DOI: 10.1016/J.Nucmedbio.2012.03.001  1
2012 Hung LW, Villemagne VL, Cheng L, Sherratt NA, Ayton S, White AR, Crouch PJ, Lim S, Leong SL, Wilkins S, George J, Roberts BR, Pham CL, Liu X, Chiu FC, ... ... Masters CL, et al. The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. The Journal of Experimental Medicine. 209: 837-54. PMID 22473957 DOI: 10.1084/Jem.20112285  1
2012 Ryan TM, Friedhuber A, Lind M, Howlett GJ, Masters C, Roberts BR. Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42). The Journal of Biological Chemistry. 287: 16947-54. PMID 22461629 DOI: 10.1074/Jbc.M111.321778  1
2012 Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. Evaluation of the effects of treatment with sAPPα on functional and histological outcome following controlled cortical impact injury in mice. Neuroscience Letters. 515: 50-4. PMID 22445885 DOI: 10.1016/J.Neulet.2012.03.017  1
2012 Watt AD, Perez KA, Rembach AR, Masters CL, Villemagne VL, Barnham KJ. Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing. Journal of Alzheimer's Disease : Jad. 30: 323-36. PMID 22426018 DOI: 10.3233/Jad-2012-120058  1
2012 Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury. Brain Research. 1451: 87-99. PMID 22424792 DOI: 10.1016/J.Brainres.2012.02.045  1
2012 Villemagne VL, Mulligan RS, Pejoska S, Ong K, Jones G, O'Keefe G, Chan JG, Young K, Tochon-Danguy H, Masters CL, Rowe CC. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 983-9. PMID 22398958 DOI: 10.1007/S00259-012-2088-X  1
2012 Barber B, Ames D, Ellis K, Martins R, Masters C, Szoeke C. Lifestyle and late life cognitive health: sufficient evidence to act now? International Psychogeriatrics / Ipa. 24: 683-8. PMID 22313892 DOI: 10.1017/S1041610211002912  1
2012 Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, Martins RN, Masters CL, Rowe CC. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurology. 78: 477-84. PMID 22302548 DOI: 10.1212/Wnl.0B013E318246D67A  1
2012 Chételat G, Villemagne VL, Pike KE, Ellis KA, Ames D, Masters CL, Rowe CC. Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease. Neuro-Degenerative Diseases. 10: 141-4. PMID 22301812 DOI: 10.1159/000334295  1
2012 Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, O'Keefe G, Jones G, Kung HF, Pontecorvo M, Masters CL, Skovronsky DM, Rowe CC. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging. Neuro-Degenerative Diseases. 10: 161-5. PMID 22261520 DOI: 10.1159/000334535  1
2012 Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Darby D, Maruff P, The Aibl Research Group. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Clinical and Experimental Neuropsychology. 34: 345-58. PMID 22248010 DOI: 10.1080/13803395.2011.643227  1
2012 Acosta O, Fripp J, Doré V, Bourgeat P, Favreau JM, Chételat G, Rueda A, Villemagne VL, Szoeke C, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Bonner E, et al. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease. Journal of Neuroscience Methods. 205: 96-109. PMID 22226742 DOI: 10.1016/J.Jneumeth.2011.12.011  1
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0  1
2012 Johanssen VA, Barnham KJ, Masters CL, Hill AF, Collins SJ. Generating recombinant C-terminal prion protein fragments of exact native sequence. Neurochemistry International. 60: 318-26. PMID 22197912 DOI: 10.1016/J.Neuint.2011.12.006  1
2012 Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA. The role of metallobiology and amyloid-β peptides in Alzheimer's disease. Journal of Neurochemistry. 120: 149-66. PMID 22121980 DOI: 10.1111/J.1471-4159.2011.07500.X  1
2012 James SA, Volitakis I, Adlard PA, Duce JA, Masters CL, Cherny RA, Bush AI. Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radical Biology & Medicine. 52: 298-302. PMID 22080049 DOI: 10.1016/J.Freeradbiomed.2011.10.446  1
2012 Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing. International Psychogeriatrics / Ipa. 24: 197-204. PMID 21749739 DOI: 10.1017/S1041610211001335  1
2012 Head RJ, Ames DJ, Masters CL, Rowe CC, Macaulay SL. From the CSIRO Preventative Health National Research Flagship The Medical Journal of Australia. 196: 376. DOI: 10.5694/Mja12.10488  1
2012 Villemagne VL, Furumoto S, Fodero-Tavoletti M, Harada R, Mulligan RS, Kudo Y, Masters CL, Yanai K, Rowe CC, Okamura N. The challenges of tau imaging Future Neurology. 7: 409-421. DOI: 10.2217/Fnl.12.34  1
2012 Doré V, Bourgeat P, Fripp J, Acosta O, Chetelat G, Szoeke C, Ellis KA, Martins RN, Villemagne V, Masters CL, Ames D, Rowe CC, Salvado O. A surface based approach for cortical thickness comparison between PiB+ and PiB-healthy control subjects Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8314. DOI: 10.1117/12.911752  1
2012 Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Jones G, Piguet O, Hodges J, Kudo Y, Masters CL, Yanai K, Rowe CC, Okamura N. 81 In vivo tau imaging with PET Neurobiology of Aging. 33. DOI: 10.1016/J.Neurobiolaging.2012.01.099  1
2012 Masters C, Robert B, Ryan T, Lind M, Li Q-, Watt A, Cherny R, Barnham K. 49 Aβ oligomers as diagnostic and therapeutic targets for Alzheimer's disease Neurobiology of Aging. 33. DOI: 10.1016/J.Neurobiolaging.2012.01.067  1
2012 Villemagne V, Ellis K, Bourgeat P, Brown B, Jones G, Fripp J, Martins R, Salvado O, Ames D, Masters C, Rowe C. Sigmoidal kinetics of BETA-AMYLOID deposition: Twenty-year interval between normality and fully developed Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2013.08.148  1
2012 Grigg J, Cassandra S, Ellis K, Rowe C, Desmond P, Masters C, Ames D. AiblWHAP: Methodology and baseline characteristics of a population-based sample recruited for a longitudinal study of risk factors and later-life cognitive decline Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.888  1
2012 Appannah A, Szoeke C, Ellis K, Rowe C, Martins R, Masters C, Ames D, Bush A. Investigating cardiovascular risk factors on cognition: A two-cohort study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.878  1
2012 Faux N, Burnham S, Wilson B, Jones G, Laws S, Bedo J, Ames D, Bush A, Doecke J, Ellis K, Head R, Kiiveri H, Macaulay L, Martins R, Masters C, et al. An update on an AIBL blood-based biomarker panel for the prediction of Aβ burden Alzheimers & Dementia. 8: 283. DOI: 10.1016/J.Jalz.2012.05.764  1
2012 Watt A, Perez K, Sherratt N, Rembach A, Hung L, McLean C, Fodero-Tavoletti M, Masters C, Villemagne V, Barnham K. Profiling beta-amyloid in the Alzheimer's disease brain Alzheimers & Dementia. 8: 270. DOI: 10.1016/J.Jalz.2012.05.724  1
2012 Watt A, Perez K, Rembach A, Masters C, Villemagne V, Barnham K. Variability in blood-based beta-amyloid assays: The need for consensus on preanalytical processing Alzheimers & Dementia. 8: 270. DOI: 10.1016/J.Jalz.2012.05.723  1
2012 Becker J, Koeppe R, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, Brickman A, Ghetti B, Masters C, et al. FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.655  1
2012 Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, ... ... Masters C, et al. O2-06-01: Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study Alzheimer's & Dementia. 8: P244-P245. DOI: 10.1016/J.Jalz.2012.05.654  1
2012 Burnham S, Graham P, Wilson B, Ames D, Macaulay L, Martins R, Masters C, Maruff P, Rowe C, Szoeke C, Ryan L, Ellis K. Intensity of dementia through latent variable modelling (I-DeLV) in the AIBL cohort Alzheimers & Dementia. 8: 131. DOI: 10.1016/J.Jalz.2012.05.347  1
2012 Burnham S, Wilson B, Graham P, Kiiveri H, Ames D, Macaulay L, Martins R, Masters C, Rowe C, Salvado O, Szoeke C, Villemagne V, Ellis K. Cognitive assessments as estimators of neocortical beta-amyloid burden in the AIBL cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.346  1
2012 Villemagne V, Ellis K, Chetelat G, Brown B, Bourgeat P, Jones G, Martins R, Salvado O, Ames D, Masters C, Rowe C. Relation between rates of Aβ deposition, APOE genotype and cognition: Results from a 3- to 5-year longitudinal study Alzheimers & Dementia. 8: 113. DOI: 10.1016/J.Jalz.2012.05.293  1
2012 Gupta VB, Wilson A, Rainey-Smith S, Laws S, Bush A, Ellis K, Macaulay L, Rowe C, Szoeke C, Taddei K, Ames D, Masters C, Martins R. Establishing apolipoprotein E as a biomarker for Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.285  1
2012 Rowe C, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, Cselényi Z, Masters C, Villemagne V. Head-to-head comparison of 11C-PiB and 18F-AZD4694 for beta-amyloid imaging in aging and dementia Alzheimers & Dementia. 8: 91. DOI: 10.1016/J.Jalz.2012.05.223  1
2012 Rainey-Smith S, Brown B, Ruyck KD, Laws S, Wilson A, Gupta VB, Ames D, Ellis K, Taddei K, Head R, Macaulay L, Masters C, Rowe C, Szoeke C, Martins R. Alzheimer's disease-related changes in plasma brain-derived neurotrophic factor levels: Data from the AIBL study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.2035  1
2012 Laws S, Bender S, Rainey-Smith S, Wilson A, Gupta VB, Ruyck Kd, Bush A, Ellis K, Macaulay L, Rowe C, Szoeke C, Taddei K, Ames D, Masters C, Martins R. Alzheimer's disease–related changes in plasma cortisol levels and gene involvement in the AIBL study Alzheimers & Dementia. 8: 407. DOI: 10.1016/J.Jalz.2012.05.2034  1
2012 Laws S, Lam C, Mondal A, Bush A, Ellis K, Macaulay L, Rowe C, Taddei K, Szoeke C, Ames D, Masters C, Martins R. Gene combination associations with Alzheimer's disease risk and quantitative traits in the AIBL study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1838  1
2012 Kinnunen K, Cash D, Leung K, Liang Y, Cardoso M, Modat M, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, ... ... Masters C, et al. Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.172  1
2012 Restrepo C, Saling M, Yates P, Villemagne V, Ames D, Bush A, Faux N, Martins R, Masters C, Rowe C, Szoeke C, Ellis K. The effect of vascular risk factors on cognition in older adults: Data from the AIBL study Alzheimers & Dementia. 8: 635. DOI: 10.1016/J.Jalz.2012.05.1693  1
2012 Yates P, Desmond P, Raniga P, Phal P, Steward C, Salvado O, Martins R, Salinas S, Ellis K, Szoeke C, Masters C, Ames D, Villemagne V, Rowe C. Incidence and Associations of Lobar Microbleeds: Results From the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (Aibl) Alzheimers & Dementia. 8: 33-33. DOI: 10.1016/J.Jalz.2012.05.1642  1
2012 Lim YY, Harrington K, Ellis K, Ames D, Ashwood T, Jaeger J, Lachovitzki R, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Darby D, Maruff P. The Australian Imaging, Biomarkers and Lifestyle-Rate of Change sub-study (AIBL-ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment Alzheimers & Dementia. 8: 557. DOI: 10.1016/J.Jalz.2012.05.1500  1
2012 Ellis K, Lim YY, Ames D, Darby D, Harrington K, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Maruff P. Aβ amyloid, cognition and APOE genotype in the preclinical stages of Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1499  1
2012 Kamer A, Ellis K, Kinsella G, Ames D, Martins R, Rowe C, Macaulay L, Szoeke C, Masters C. APOE and cognitive dysfunction in Alzheimer's dementia and mild cognitive impairment Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1441  1
2012 Raffelt D, Tournier JD, Crozier S, Ellis K, Martins R, Villemagne V, Masters C, Ames D, Rowe C, Salvado O, Connelly A. Apparent fibre density: A novel MRI approach that identifies specific white matter tracts affected in Alzheimer's disease and MCI Alzheimers & Dementia. 8: 61-61. DOI: 10.1016/J.Jalz.2012.05.142  1
2012 Cyarto E, Cox K, Desmond P, Ames D, Szoeke C, Salvado O, Sharman M, Ellis K, Phal P, Masters C, Rowe C, Martins R, Lautenschlager N. AIBL ACTIVE: A randomized controlled trial of physical activity to delay the progression of white matter hyperintensities on MRI in older adults at risk of cognitive decline Alzheimers & Dementia. 8: 506. DOI: 10.1016/J.Jalz.2012.05.1377  1
2012 Gardener S, Rainey-Smith S, Gu Y, Taddei K, Laws S, Gupta VB, Ames D, Ellis K, Head R, Macaulay L, Masters C, Rowe C, Szoeke C, Clifton P, Keogh J, et al. Diet, neuroimaging biomarkers and Alzheimer's disease: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing Alzheimers & Dementia. 8: 503. DOI: 10.1016/J.Jalz.2012.05.1365  1
2012 Brown B, Peiffer J, Gupta VB, Taddei K, Salvado O, Villemagne V, Rainey-Smith S, Ellis K, Ames D, Rowe C, Masters C, Szoeke C, Martins R. Level of physical activity is associated with hippocampal volume in a subgroup of the AIBL cohort Alzheimers & Dementia. 8: 494. DOI: 10.1016/J.Jalz.2012.05.1341  1
2012 Szoeke C, Ellis K, Zhang P, Rowe C, Martins R, Masters C, Ames D. A return to clinical skills in the early diagnosis of Alzheimer's disease Alzheimers & Dementia. 8: 491. DOI: 10.1016/J.Jalz.2012.05.1331  1
2012 Benzinger T, Blazey T, Koeppe R, Jack C, Raichle M, Su Y, Snyder A, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Masters C, et al. Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.132  1
2012 Ellis K, Maruff P, Martins R, Masters C, McBride S, Macaulay L, Rowe C, Rainey-Smith S, Rembach A, Savage G, Szoeke C, Taddei K, Villemagne V, Zhang P, Ames D. Rates of conversion to MCI and Alzheimer's in the Australian Imaging, Biomarkers and Lifestyle (AIBL) cohort over 36 months Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1312  1
2012 Lim YY, Ellis K, Ames D, Harrington K, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Pietrzak R, Maruff P. Effect of Aβ burden and apolipoprotein E-ε4 on cognitive decline at 18 months in healthy older adults Alzheimers & Dementia. 8: 439. DOI: 10.1016/J.Jalz.2012.05.1168  1
2012 Rowe C, Ellis K, Brown B, Bourgeat P, Faux N, Martins R, Salvado O, Masters C, Ames D, Villemagne V. Cognition, hippocampal volume and fibrillar Aβ burden as predictors of cognitive decline: Three-year follow-up results from AIBL Alzheimers & Dementia. 8: 433. DOI: 10.1016/J.Jalz.2012.05.1154  1
2012 Dore V, Fripp J, Bourgeat P, Acosta O, Zhou L, Raniga P, Martins R, Macaulay L, Ellis K, Masters C, Ames D, Villemagne V, Rowe C, Salvado O. Longitudinal analysis of cortical thickness in PiB+ and PiB- healthy elderly controls Alzheimers & Dementia. 8: 34. DOI: 10.1016/J.Jalz.2012.05.088  1
Show low-probability matches.